syndrome	score	normalized_score
PHACE ASSOCIATION	2.5	100.0
RECURRENT ACUTE PANCREATITIS	2.37585073	95.03402919999999
AFRICAN IRON OVERLOAD	1.8018226700000002	72.0729068
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.4601572	58.406288
HEPATOCELLULAR CARCINOMA	1.33414411	53.3657644
AUTOIMMUNE HEPATITIS	1.2824633799999998	51.298535199999996
SECKEL SYNDROME 10; SCKL10	1.25934579	50.373831599999995
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	1.1972155599999998	47.88862239999999
HEPATOCELLULAR CARCINOMA	1.1145833	44.583332000000006
STURGE-WEBER SYNDROME	1.0833333	43.333332
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	1.083333	43.33332
NON-INVOLUTING CONGENITAL HEMANGIOMA	1.083333	43.33332
CRANIOECTODERMAL DYSPLASIA 1	1.0726332	42.905328000000004
WILSON DISEASE	1.04164923	41.6659692
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	1.0204082	40.816328
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	1.01773763	40.7095052
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.01497094	40.598837599999996
MEVALONIC ACIDURIA; MEVA	1.01041508	40.4166032
MOSAIC TRISOMY 1	1.00994383	40.397753200000004
ATELOSTEOGENESIS TYPE II	1.00532136	40.2128544
PREECLAMPSIA	1.00392157	40.1568628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	1.00163132	40.0652528
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	40.0
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	40.0
NORRIE DISEASE	1.0	40.0
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	40.0
CONGENITAL MACROGLOSSIA	1.0	40.0
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.0	40.0
LOWRY-MACLEAN SYNDROME	1.0	40.0
PRIMARY SCLEROSING CHOLANGITIS	0.9778224600000001	39.1128984
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.9759633999999999	39.03853599999999
ISOLATED BILIARY ATRESIA	0.8873094400000001	35.492377600000005
MARTINEZ-FRIAS SYNDROME	0.833333	33.33332
JUVENILE POLYPOSIS SYNDROME	0.8013090399999999	32.0523616
KASABACH-MERRITT SYNDROME	0.787037	31.48148
SOMATOSTATINOMA	0.7064654800000001	28.258619200000002
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.7036900399999999	28.147601599999994
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.7	27.999999999999996
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.66588155	26.635262000000004
BECKWITH-WIEDEMANN SYNDROME	0.6599990500000001	26.399962000000006
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.6582567500000001	26.33027
ALAGILLE SYNDROME 1; ALGS1	0.60100759	24.0403036
GALLBLADDER NEUROENDOCRINE TUMOR	0.5839289000000001	23.357156000000003
MECKEL SYNDROME, TYPE 6; MKS6	0.5692983	22.771932
PETERS-PLUS SYNDROME; PTRPLS	0.56812364	22.7249456
LATHOSTEROLOSIS	0.56760109	22.704043600000002
MECKEL SYNDROME	0.5666667	22.666667999999998
METACHROMATIC LEUKODYSTROPHY	0.5625	22.5
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.5625	22.5
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.55918473	22.3673892
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.55526316	22.2105264
RING CHROMOSOME 13 SYNDROME	0.54378286	21.7513144
ALAGILLE SYNDROME	0.5410805500000001	21.643222000000005
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.53922557	21.569022800000003
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.52650162	21.0600648
SPLENOPORTAL VASCULAR ANOMALIES	0.52536235	21.014494
SICKLE CELL ANEMIA	0.5222222	20.888888
GRAFT VERSUS HOST DISEASE	0.52123293	20.8493172
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.50848064	20.339225600000002
BRANCHIOSKELETOGENITAL SYNDROME	0.50657895	20.263157999999997
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.50406537	20.162614799999997
MOSAIC TRISOMY 9	0.50342466	20.136986399999998
XYLT1-CDG	0.50170358	20.0681432
DIAPHANOSPONDYLODYSOSTOSIS	0.50163132	20.0652528
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5	20.0
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.5	20.0
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.5	20.0
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.5	20.0
SPONDYLOPERIPHERAL DYSPLASIA	0.5	20.0
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.5	20.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	20.0
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.5	20.0
ANGIOMA, TUFTED	0.5	20.0
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.5	20.0
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	20.0
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.5	20.0
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.5	20.0
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	20.0
MAFFUCCI SYNDROME	0.5	20.0
MANDIBULOACRAL DYSPLASIA	0.5	20.0
PRIMARY BILIARY CHOLANGITIS	0.49442811	19.777124399999998
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.44267879	17.7071516
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.43304545999999994	17.321818399999998
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.42593512999999994	17.0374052
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.41710542	16.6842168
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.41654979000000003	16.6619916
8Q24.3 MICRODELETION SYNDROME	0.41633538000000003	16.6534152
KLATSKIN TUMOR	0.41172834	16.469133600000003
NEUROFIBROMATOSIS TYPE 1	0.4102561	16.410244000000002
IMMUNE DEFICIENCY DISEASE	0.4047616	16.190464
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.39389202999999995	15.7556812
SILVER-RUSSELL SYNDROME; SRS	0.39380381	15.7521524
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.3897059	15.588236
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.37871375999999995	15.1485504
SARCOIDOSIS	0.37495938	14.9983752
GLYCOGEN STORAGE DISEASE IA	0.37020815	14.808326
GLYCOGEN STORAGE DISEASE IB	0.37020815	14.808326
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.36925798	14.770319199999998
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.36760045999999996	14.704018399999999
LYSINURIC PROTEIN INTOLERANCE	0.35970199999999997	14.388079999999997
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.35794449999999994	14.317779999999997
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.35333557	14.1334228
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.34829544999999995	13.931817999999998
CHYLOMICRON RETENTION DISEASE	0.34660036	13.864014399999999
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.34535572	13.8142288
BLOOM SYNDROME	0.344322	13.77288
AYME-GRIPP SYNDROME; AYGRP	0.34333661	13.7334644
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.34188589999999996	13.675436
CODAS SYNDROME	0.34154326999999995	13.661730799999999
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.33895814999999996	13.558325999999997
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.33859616	13.543846399999998
16P12.1P12.3 TRIPLICATION SYNDROME	0.33849788999999997	13.539915599999999
C SYNDROME	0.33838898	13.5355592
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.33503688	13.401475199999998
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.33503658	13.4014632
MITCHELL-RILEY SYNDROME; MTCHRS	0.3333333	13.333332
CLEFT VELUM	0.333333	13.333319999999999
PALLISTER-HALL SYNDROME	0.333333	13.333319999999999
TREACHER-COLLINS SYNDROME	0.333333	13.333319999999999
%109500 BASILAR IMPRESSION, PRIMARY	0.333333	13.333319999999999
CARNEY-STRATAKIS SYNDROME	0.333333	13.333319999999999
EPISODIC ATAXIA TYPE 1	0.333333	13.333319999999999
PALLISTER-HALL SYNDROME	0.333333	13.333319999999999
CHOLANGIOCARCINOMA	0.333333	13.333319999999999
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.333333	13.333319999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.333333	13.333319999999999
CLEIDOCRANIAL DYSPLASIA	0.333333	13.333319999999999
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.333333	13.333319999999999
APOLIPOPROTEIN A-I; APOA1	0.333333	13.333319999999999
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.33018661	13.2074644
DUODENAL NEUROENDOCRINE TUMOR	0.32535017	13.0140068
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.31908664999999997	12.763465999999998
ROBERTS SYNDROME; RBS	0.3026316	12.105264
SCLEROSING CHOLANGITIS, NEONATAL	0.29839536	11.9358144
CHOLANGIOCARCINOMA	0.29693016	11.8772064
SMITH-LEMLI-OPITZ SYNDROME	0.29672297999999997	11.868919199999999
FRONTOOCULAR SYNDROME	0.29209298	11.6837192
PEUTZ-JEGHERS SYNDROME	0.291667	11.66668
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.28888256	11.5553024
VON HIPPEL-LINDAU DISEASE	0.284656	11.38624
PMM2-CDG	0.28066937999999997	11.226775199999999
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.28061333	11.2245332
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.28061333	11.2245332
WILSON DISEASE	0.27892975	11.157189999999998
LEPTOSPIROSIS	0.27737493999999996	11.094997599999997
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.27456146000000003	10.982458400000002
VIPOMA	0.27313218	10.9252872
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.2722222	10.888888000000001
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.27221555999999997	10.8886224
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.27221555999999997	10.8886224
BARE LYMPHOCYTE SYNDROME, TYPE II	0.2714286	10.857144
GCGR-RELATED HYPERGLUCAGONEMIA	0.2712766	10.851064
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.2712766	10.851064
ARGININOSUCCINIC ACIDURIA	0.26837027999999996	10.734811199999998
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.26683558	10.673423200000002
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.26666670000000003	10.666668000000001
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.26566238999999997	10.6264956
ALSTROM SYNDROME; ALMS	0.26497094	10.5988376
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.26255549	10.5022196
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.26211866	10.4847464
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.26058073	10.4232292
118900 CIRRHOSIS, FAMILIAL	0.25869565	10.347826
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.25869565	10.347826
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.25869565	10.347826
DISTAL TRISOMY 5Q	0.25821026999999996	10.328410799999999
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.25812482999999997	10.324993199999998
8P INVERTED DUPLICATION/DELETION SYNDROME	0.25704225	10.281690000000001
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.25696673999999997	10.278669599999999
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.25562515	10.225006
GLYCOGEN STORAGE DISEASE VI	0.25562514999999997	10.225005999999999
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25562514999999997	10.225005999999999
LAMBERT SYNDROME	0.25526316	10.210526400000001
LAMBERT SYNDROME	0.25526316	10.210526400000001
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.25505598	10.202239200000001
TRISOMY 8P	0.25342466	10.1369864
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.25170358	10.068143199999998
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.25170358	10.068143199999998
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25170358	10.068143199999998
GLYCOGEN STORAGE DISEASE IXB	0.25170358	10.068143199999998
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.25	10.0
KETAMINE-INDUCED BILIARY DILATATION	0.25	10.0
DYSTONIA 6, TORSION	0.25	10.0
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25	10.0
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.25	10.0
MENTAL RETARDATION, BUENOS AIRES TYPE	0.25	10.0
MEDULLARY THYROID CARCINOMA	0.25	10.0
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.25	10.0
NEUROFIBROMA	0.25	10.0
HYPERPARATHYROIDISM 2	0.25	10.0
ROBERTS SYNDROME	0.25	10.0
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	10.0
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.23972692	9.5890768
HEMOCHROMATOSIS, NEONATAL	0.23925155	9.570062
WILLIAMS SYNDROME	0.23743049000000002	9.497219600000001
FIBROSCLEROSIS, MULTIFOCAL	0.237037	9.481480000000001
LIVER FAILURE, INFANTILE, TRANSIENT	0.23312223	9.3248892
GRFOMA	0.23127565000000005	9.251026000000003
TETRASOMY 9P	0.22993368	9.1973472
PPOMA	0.22774208000000004	9.109683200000001
PHACE SYNDROME	0.22751299999999997	9.100519999999998
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.22653976	9.0615904
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.22584705	9.033882
HALOTHANE HEPATITIS	0.22567136	9.0268544
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.22536247	9.0144988
BETA-THALASSEMIA INTERMEDIA	0.22309419	8.9237676
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.22272730000000002	8.909092000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.21980629000000002	8.7922516
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.21958396000000002	8.783358400000001
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.21933376	8.773350399999998
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.21837028000000003	8.734811200000001
NAVAJO NEUROHEPATOPATHY	0.21624390000000002	8.649756
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.21326736000000002	8.530694400000002
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.21307246000000002	8.5228984
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.21281197000000002	8.5124788
GAUCHER DISEASE TYPE 1	0.21039923000000002	8.415969200000001
AYMÉ-GRIPP SYNDROME	0.21000361	8.4001444
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.20934579	8.3738316
7Q11.23 MICRODUPLICATION SYNDROME	0.20704225	8.28169
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.20696674	8.2786696
GLUCAGONOMA	0.20646548000000003	8.258619200000002
HEMIFACIAL MICROSOMIA	0.20641026	8.2564104
SCARF SYNDROME	0.20516489000000002	8.206595600000002
CARCINOID SYNDROME	0.20392157000000002	8.1568628
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.20271637	8.1086548
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.20215656	8.0862624
ISOLATED POLYCYSTIC LIVER DISEASE	0.20170358000000002	8.068143200000002
CRYOGLOBULINEMIC VASCULITIS	0.20170358000000002	8.068143200000002
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.2	8.0
MODY	0.2	8.0
HYPERCALCEMIA, INFANTILE, 1	0.2	8.0
HEPATIC ADENOMAS, FAMILIAL	0.2	8.0
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.2	8.0
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.2	8.0
HEMANGIOBLASTOMA	0.2	8.0
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.2	8.0
KEPPEN-LUBINSKY SYNDROME	0.2	8.0
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	8.0
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.2	8.0
CAYLER CARDIOFACIAL SYNDROME	0.2	8.0
AXIAL OSTEOMALACIA	0.2	8.0
RETINAL CAPILLARY MALFORMATION	0.2	8.0
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	8.0
CARNEY COMPLEX	0.2	8.0
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.2	8.0
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.19320676	7.7282704
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.19128675	7.651470000000001
NEPHRONOPHTHISIS 18; NPHP18	0.1888892	7.555568
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18841515	7.536606
VACTERL/VATER ASSOCIATION	0.1875	7.5
GRACILE SYNDROME	0.18312063999999997	7.324825599999999
CAROLI DISEASE, ISOLATED	0.17972128	7.1888512
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17771637	7.1086548
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.17535276	7.0141104
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.17498253000000002	6.9993012000000006
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17448915999999998	6.9795663999999995
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.17370925	6.948370000000001
LEIGH SYNDROME; LS	0.17351632	6.9406528
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.1719299	6.877196
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.17183189000000001	6.8732756
FRYNS SYNDROME; FRNS	0.17020057000000002	6.808022800000001
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.17009166	6.8036664
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.16837058000000002	6.734823200000001
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.16829832	6.7319328
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.16829832	6.7319328
MOSAIC MONOSOMY X	0.16724523000000002	6.689809200000001
TURNER SYNDROME	0.16724523000000002	6.689809200000001
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.16724523000000002	6.689809200000001
MONOSOMY X	0.16724523000000002	6.689809200000001
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.166667	6.6666799999999995
HYPERPLASTIC POLYPOSIS SYNDROME	0.166667	6.6666799999999995
PELVIS-SHOULDER DYSPLASIA	0.166667	6.6666799999999995
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.166667	6.6666799999999995
YELLOW NAIL SYNDROME	0.166667	6.6666799999999995
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.166667	6.6666799999999995
FAMILIAL PANCREATIC CARCINOMA	0.15932823000000002	6.373129200000001
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.15882677	6.3530708
KAPOSI SARCOMA	0.1587761	6.351044
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.15829547000000002	6.3318188000000015
SCHINZEL-GIEDION SYNDROME	0.15829547000000002	6.3318188000000015
DISTAL MONOSOMY 12Q	0.14981842	5.9927368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14926725999999998	5.970690399999999
WOLF-HIRSCHHORN SYNDROME	0.14837042	5.9348168
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14654704	5.861881599999999
TRANSALDOLASE DEFICIENCY	0.14364684000000003	5.745873600000001
GANGLIONEUROMA	0.14285699999999998	5.71428
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.71428
ACERULOPLASMINEMIA	0.14285699999999998	5.71428
RARE HEREDITARY HEMOCHROMATOSIS	0.14202905	5.681162
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.14058177000000002	5.6232708
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.1397059	5.588236
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.13952649	5.581059600000001
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.1359649	5.4385959999999995
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.13491817	5.3967268
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.13326498000000003	5.330599200000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.1307751	5.231004
FUCOSIDOSIS	0.13023715000000002	5.209486000000001
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.12853357	5.1413428
BRANCHIOOCULOFACIAL SYNDROME	0.12842466	5.1369864000000005
MICROCEPHALY, AUTOSOMAL DOMINANT	0.12842466	5.1369864000000005
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.12782273	5.1129092
TRIPLOIDY	0.12670358	5.068143200000001
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.125	5.0
ULBRIGHT-HODES SYNDROME	0.125	5.0
RENAL AGENESIS	0.125	5.0
LIGNEOUS CONJUNCTIVITIS	0.125	5.0
GENITOPALATOCARDIAC SYNDROME	0.125	5.0
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.125	5.0
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.125	5.0
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.12379496000000001	4.9517984
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.12376265	4.950506000000001
HARDIKAR SYNDROME	0.12027861000000001	4.8111444
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.11747741000000002	4.699096400000001
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.1150926	4.6037040000000005
LYSOSOMAL ACID LIPASE DEFICIENCY	0.11482273000000003	4.592909200000001
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.11326736000000001	4.5306944
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.11261722	4.5046888
BETA-THALASSEMIA MAJOR	0.11095192	4.4380768
BLUE RUBBER BLEB NEVUS	0.110119	4.40476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.10855290000000001	4.342116
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.10686847000000001	4.274738800000001
LIG4 SYNDROME	0.10675956	4.2703824
KIKUCHI-FUJIMOTO DISEASE	0.10562515	4.225006
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.10562515	4.225006
BUDD-CHIARI SYNDROME	0.10533975999999999	4.213590399999999
TRICHOTHIODYSTROPHY	0.10516489000000001	4.2065956
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.10461815000000002	4.184726000000001
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.1046099	4.184396
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.10450580000000001	4.180232
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10438218000000002	4.175287200000001
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.10392157	4.156862800000001
MELIOIDOSIS	0.10374150000000001	4.149660000000001
PROTEUS SYNDROME	0.10313364	4.1253456
SYNDROMIC DIARRHEA	0.10218457	4.0873828
MONOSOMY 13Q14	0.10163132000000001	4.0652528000000006
MALAN OVERGROWTH SYNDROME	0.10073256000000001	4.029302400000001
POLYARTERITIS NODOSA	0.1	4.0
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.1	4.0
CERNUNNOS-XLF DEFICIENCY	0.1	4.0
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.1	4.0
JUVENILE HYALINE FIBROMATOSIS	0.1	4.0
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.1	4.0
MANTLE CELL LYMPHOMA	0.1	4.0
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.1	4.0
HEREDITARY ACROKERATOTIC POIKILODERMA	0.1	4.0
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.1	4.0
PSEUDOPROGERIA SYNDROME	0.1	4.0
AICARDI SYNDROME; AIC	0.09957796000000001	3.9831184000000004
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.09934981000000001	3.9739924
ADAMS-OLIVER SYNDROME	0.09861814999999999	3.9447259999999997
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.09857076000000001	3.9428304000000005
NIEMANN-PICK DISEASE TYPE B	0.09834253	3.9337012
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.09830424	3.9321696000000004
CHARGE SYNDROME	0.09731936000000001	3.8927744
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.09648326000000002	3.859330400000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.09602588000000001	3.8410352000000003
ENTERIC ANENDOCRINOSIS	0.0946844	3.787376
KAGAMI-OGATA SYNDROME	0.09415590000000001	3.7662360000000006
NEPHRONOPHTHISIS 19; NPHP19	0.09322408	3.7289632000000004
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.09254042000000001	3.7016168
MICROSPORIDIOSIS	0.09183680000000001	3.6734720000000007
BOHRING-OPITZ SYNDROME	0.09178309000000001	3.6713236000000005
NEONATAL HEMOCHROMATOSIS	0.09166669999999999	3.666667999999999
RING CHROMOSOME 7 SYNDROME	0.09154357000000002	3.6617428000000007
DILATED CARDIOMYOPATHY WITH ATAXIA	0.09138403000000002	3.6553612000000006
DUBOWITZ SYNDROME	0.09137488000000002	3.654995200000001
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.09137488000000002	3.654995200000001
MENTAL RETARDATION, X-LINKED 2	0.0909091	3.6363640000000004
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0909091	3.6363640000000004
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0909091	3.6363640000000004
STUVE-WIEDEMANN SYNDROME	0.0909091	3.6363640000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0909091	3.6363640000000004
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0909091	3.6363640000000004
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0909091	3.6363640000000004
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.08991225000000001	3.5964900000000006
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.08991225000000001	3.5964900000000006
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08982681	3.5930724000000005
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.08903976000000001	3.5615904000000005
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.08903976000000001	3.5615904000000005
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.08903976	3.5615903999999996
CIRRHOSIS, FAMILIAL	0.08859646000000002	3.543858400000001
KAWASAKI DISEASE	0.08817136	3.5268544
PEDIATRIC-ONSET GRAVES DISEASE	0.08781141	3.5124564000000005
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.08725487000000001	3.4901948000000003
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.08725487000000001	3.4901948000000003
CHROMOSOME 16P13.3 DELETION SYNDROME	0.08702334000000002	3.480933600000001
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.08688435	3.475374
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0863719	3.4548759999999996
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0858878	3.435512
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.08503688000000001	3.4014752
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.08503688000000001	3.4014752
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.08503688000000001	3.4014752
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.08503688000000001	3.4014752
CHRONIC GRANULOMATOUS DISEASE	0.08503688000000001	3.4014752
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.08496462000000002	3.3985848000000005
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.08496462000000002	3.3985848000000005
WARSAW BREAKAGE SYNDROME; WABS	0.08496462000000002	3.3985848000000005
SILLENCE SYNDROME	0.08496462000000002	3.3985848000000005
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.08496462000000002	3.3985848000000005
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.08477143000000001	3.3908572000000006
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08477143000000001	3.3908572000000006
HEMOCHROMATOSIS TYPE 4	0.08470813999999999	3.3883255999999995
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.08465600000000001	3.38624
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.08465600000000001	3.38624
STURGE-WEBER SYNDROME	0.08465600000000001	3.38624
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.08396535000000001	3.358614
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08377242000000001	3.3508968000000006
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.08333330000000001	3.333332000000001
LARYNGOTRACHEAL ANGIOMA	0.08333330000000001	3.333332000000001
DISTAL 16P11.2 MICRODELETION SYNDROME	0.08333330000000001	3.333332000000001
CAMPOMELIC DYSPLASIA	0.08333330000000001	3.333332000000001
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.08333330000000001	3.333332000000001
PAPILLON-LEFÈVRE SYNDROME	0.08333330000000001	3.333332000000001
PENTALOGY OF CANTRELL	0.08333330000000001	3.333332000000001
NOCARDIOSIS	0.08333330000000001	3.333332000000001
THANATOPHORIC DYSPLASIA, TYPE II	0.08333330000000001	3.333332000000001
THANATOPHORIC DYSPLASIA, TYPE I	0.08333330000000001	3.333332000000001
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.08333330000000001	3.333332000000001
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.08333330000000001	3.333332000000001
184705 STEINFELD SYNDROME	0.08333330000000001	3.333332000000001
TUFTED ANGIOMA	0.08333330000000001	3.333332000000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.08333330000000001	3.333332000000001
LARON SYNDROME	0.08333330000000001	3.333332000000001
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.08333330000000001	3.333332000000001
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.08333330000000001	3.333332000000001
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.08333330000000001	3.333332000000001
MELNICK-NEEDLES SYNDROME	0.08333330000000001	3.333332000000001
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.08333330000000001	3.333332000000001
NATIVE AMERICAN MYOPATHY	0.08333330000000001	3.333332000000001
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.08333330000000001	3.333332000000001
PULMONARY ARTERIOVENOUS MALFORMATION	0.08333330000000001	3.333332000000001
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.08333330000000001	3.333332000000001
2Q24 MICRODELETION SYNDROME	0.08333330000000001	3.333332000000001
3C SYNDROME	0.08333330000000001	3.333332000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.08084467000000001	3.2337868000000007
DISORDER OF BILE ACID SYNTHESIS	0.07877537	3.1510148
CLASSIC MYCOSIS FUNGOIDES	0.07862668	3.1450671999999997
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.07839534000000001	3.1358136
SIMPSON-GOLABI-BEHMEL SYNDROME	0.07829707000000001	3.1318828000000005
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.07824334	3.1297335999999993
ALAGILLE SYNDROME 2	0.07792211	3.1168844
CRIGLER-NAJJAR SYNDROME TYPE 1	0.0776316	3.105264
NEUTRAL LIPID STORAGE MYOPATHY	0.07747094	3.0988376
OROFACIODIGITAL SYNDROME I; OFD1	0.07733988	3.0935951999999998
ADAMS-OLIVER SYNDROME 5; AOS5	0.0772059	3.0882359999999998
PINEOCYTOMA	0.07692310000000001	3.0769240000000004
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	3.0769240000000004
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	3.0769240000000004
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.07692310000000001	3.0769240000000004
N SYNDROME	0.07692310000000001	3.0769240000000004
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.07692310000000001	3.0769240000000004
DERMOODONTODYSPLASIA	0.07692310000000001	3.0769240000000004
DERMATOMYOSITIS	0.07692310000000001	3.0769240000000004
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	3.0769240000000004
ZOLLINGER-ELLISON SYNDROME	0.07669176000000001	3.067670400000001
BECKWITH-WIEDEMANN SYNDROME	0.07666575	3.06663
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07655684	3.0622736
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.07645373000000001	3.0581492000000003
ACROCEPHALOSYNDACTYLY	0.07607428	3.0429711999999998
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0759638	3.038552
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0759638	3.038552
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0754985	3.0199399999999996
ILEAL NEUROENDOCRINE TUMOR	0.07535017000000001	3.0140068
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.07535017000000001	3.0140068
JEJUNAL NEUROENDOCRINE TUMOR	0.07535017000000001	3.0140068
LOEYS-DIETZ SYNDROME 5	0.07528663000000001	3.0114652000000004
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07485326	2.9941304000000004
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07485326	2.9941304000000004
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07485326	2.9941304000000004
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.07321722	2.9286888
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.07313218	2.9252872
CARDIOFACIOCUTANEOUS SYNDROME	0.07269002000000001	2.9076008000000004
DK1-CDG	0.07229184999999999	2.8916739999999996
GRANT SYNDROME	0.07181271	2.8725084
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.8571440000000004
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.07142860000000001	2.8571440000000004
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.07142860000000001	2.8571440000000004
3MC SYNDROME 2	0.07142860000000001	2.8571440000000004
CRYPTOSPORIDIOSIS	0.07142860000000001	2.8571440000000004
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07142860000000001	2.8571440000000004
GARDNER SYNDROME	0.07142860000000001	2.8571440000000004
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.07142860000000001	2.8571440000000004
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07142860000000001	2.8571440000000004
3MC SYNDROME	0.07142860000000001	2.8571440000000004
TURCOT SYNDROME WITH POLYPOSIS	0.07142860000000001	2.8571440000000004
3MC SYNDROME 3	0.07142860000000001	2.8571440000000004
3MC SYNDROME 1	0.07142860000000001	2.8571440000000004
AICARDI SYNDROME	0.07142860000000001	2.8571440000000004
PSORIASIS 14, PUSTULAR	0.07142860000000001	2.8571440000000004
HEMOCHROMATOSIS TYPE 2	0.07058827	2.8235308
MUCOLIPIDOSIS TYPE II	0.06936847	2.7747388
JOUBERT SYNDROME 6	0.06929830000000001	2.771932
BARDET-BIEDL SYNDROME 1; BBS1	0.06929830000000001	2.771932
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.06923858	2.7695431999999998
LINEAR NEVUS SEBACEUS SYNDROME	0.06891026	2.7564104
DISTAL MONOSOMY 7Q36	0.06882711	2.7530843999999997
LAURENCE-MOON SYNDROME	0.06829802	2.7319208
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.06829802	2.7319208
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.06766489	2.7065956
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.06703377	2.6813508
GLYCOGEN STORAGE DISEASE IXC	0.0669524	2.678096
NEPHROBLASTOMA	0.0666667	2.6666679999999996
RHABDOID TUMOR	0.0666667	2.6666679999999996
MPI-CDG	0.0666667	2.6666679999999996
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0666667	2.6666679999999996
SUBEPENDYMOMA	0.0666667	2.6666679999999996
EPENDYMOMA	0.0666667	2.6666679999999996
ADENOCARCINOMA OF THE ANAL CANAL	0.0666667	2.6666679999999996
MUIR-TORRE SYNDROME	0.0666667	2.6666679999999996
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.0666667	2.6666679999999996
SENIOR-LOKEN SYNDROME	0.0666667	2.6666679999999996
REYNOLDS SYNDROME	0.06644391000000001	2.6577564000000007
CHROMOSOME 2Q37 DELETION SYNDROME	0.06613142	2.6452568
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.06566812000000001	2.6267248000000003
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.06449484999999999	2.5797939999999997
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.06413132	2.5652528
HURLER SYNDROME	0.06406065	2.562426
ASPARTYLGLUCOSAMINURIA	0.06406065	2.562426
COSTELLO SYNDROME	0.06398839	2.5595356000000002
CEREBROOCULONASAL SYNDROME	0.06387948	2.5551792
COG4-CDG	0.06312692	2.5250768
CITRULLINEMIA TYPE II	0.06288764	2.5155056
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0625	2.5
HUMERO-RADIO-ULNAR SYNOSTOSIS	0.0625	2.5
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0625	2.5
HEMANGIOMAS OF SMALL INTESTINE	0.0625	2.5
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0625	2.5
COWDEN SYNDROME	0.0625	2.5
X-LINKED CENTRONUCLEAR MYOPATHY	0.0625	2.5
SMITH-MAGENIS SYNDROME	0.062248160000000004	2.4899264
CARTILAGE-HAIR HYPOPLASIA	0.0621584	2.486336
COACH SYNDROME	0.06128555	2.451422
ASPARTYLGLUCOSAMINURIA; AGU	0.060792750000000007	2.4317100000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.06072049	2.4288196
MENTAL RETARDATION, X-LINKED 97; MRX97	0.060580730000000006	2.4232292
FETAL ALCOHOL SYNDROME	0.06023932	2.4095728
DUBIN-JOHNSON SYNDROME	0.05959834000000001	2.3839336
BASAL CELL NEVUS SYNDROME	0.05908917	2.3635668
POLYCYSTIC KIDNEY DISEASE 2	0.05904186	2.3616744
HOLOPROSENCEPHALY 7	0.05898026000000001	2.3592104000000003
RAMOS-ARROYO SYNDROME	0.05898026000000001	2.3592104000000003
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0588235	2.35294
RECOMBINANT 8 SYNDROME	0.0588235	2.35294
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0588235	2.35294
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0588235	2.35294
ALEXANDER DISEASE	0.0588235	2.35294
CRISPONI SYNDROME	0.0588235	2.35294
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0587761	2.351044
PRIMARY MYELOFIBROSIS	0.05874668000000001	2.3498672000000007
DUBIN-JOHNSON SYNDROME	0.05789476	2.3157904
CYSTIC FIBROSIS	0.05725918000000001	2.2903672000000004
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.05718692	2.2874768
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.05655317	2.2621268
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.05632164	2.2528656000000002
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.05616517	2.2466068
INSULIN-RESISTANCE SYNDROME TYPE B	0.055555600000000004	2.222224
RECOMBINANT CHROMOSOME 8 SYNDROME	0.055555600000000004	2.222224
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.055555600000000004	2.222224
SCHEIE SYNDROME	0.055555600000000004	2.222224
SMITH-MAGENIS SYNDROME; SMS	0.055555600000000004	2.222224
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.055555600000000004	2.222224
PIERPONT SYNDROME	0.055555600000000004	2.222224
BILIARY CIRRHOSIS, PRIMARY	0.055555600000000004	2.222224
CYSTIC FIBROSIS	0.055555600000000004	2.222224
POLYCYSTIC LIVER DISEASE 2	0.054335180000000004	2.1734072
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.05426292	2.1705168
OSTEOGENESIS IMPERFECTA	0.05411251	2.1645004
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.05402926	2.1611704
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0537037	2.148148
INFANTILE LIVER FAILURE SYNDROME 1	0.053432440000000005	2.1372976
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.053361780000000004	2.1344712
LATHOSTEROLOSIS	0.053334900000000005	2.1333960000000003
PEUTZ-JEGHERS SYNDROME	0.0526316	2.105264
NEPHRONOPHTHISIS 13	0.0526316	2.105264
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0526316	2.105264
POLYCYSTIC KIDNEY DISEASE 3	0.0526316	2.105264
POLYCYSTIC KIDNEYS	0.0526316	2.105264
TUBEROUS SCLEROSIS COMPLEX	0.0526316	2.105264
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0526316	2.105264
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0526316	2.105264
MECKEL SYNDROME, TYPE 5	0.0526316	2.105264
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0526316	2.105264
MECKEL SYNDROME, TYPE 4; MKS4	0.0526316	2.105264
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0526316	2.105264
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	2.105264
DDOST-CDG	0.05172886	2.0691544
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.05100921	2.0403683999999997
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.050509700000000005	2.020388
ALSTRÖM SYNDROME	0.05004307	2.0017228
MEDNIK SYNDROME	0.05	2.0
IRIDA SYNDROME	0.05	2.0
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.049322580000000005	1.9729032
PORPHYRIA CUTANEA TARDA	0.04929144	1.9716576
IMMUNODEFICIENCY 47	0.048666589999999996	1.9466636
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.04865153999999999	1.9460615999999997
FANCONI ANEMIA	0.04850324	1.9401296000000001
LYSOSOMAL ACID LIPASE DEFICIENCY	0.048459920000000004	1.9383968
INFANTILE LIVER FAILURE SYNDROME 2	0.047646230000000005	1.9058492000000002
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.047619	1.9047600000000002
OLLIER DISEASE	0.047619	1.9047600000000002
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.047619	1.9047600000000002
SECONDARY POLYCYTHEMIA	0.047619	1.9047600000000002
CEREBRAL ARTERIOVENOUS MALFORMATION	0.047619	1.9047600000000002
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.047619	1.9047600000000002
DIASTROPHIC DWARFISM	0.047619	1.9047600000000002
PERLMAN SYNDROME	0.04741415	1.8965660000000002
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.047299280000000006	1.8919712000000002
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0471623	1.886492
HEREDITARY ELLIPTOCYTOSIS	0.0462766	1.8510640000000003
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.04619231000000001	1.8476924000000001
TYROSINEMIA, TYPE I; TYRSN1	0.0455708	1.822832
HEMOCHROMATOSIS, TYPE 1	0.0455708	1.822832
HEREDITARY FRUCTOSE INTOLERANCE	0.04542824000000001	1.8171296000000003
CONGENITAL ISOLATED ACTH DEFICIENCY	0.045408199999999996	1.8163279999999997
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.04531082	1.8124328000000003
SIALURIA	0.04411484	1.7645936
GLYCOGEN STORAGE DISEASE IV	0.04399965	1.7599860000000003
POTOCKI-LUPSKI SYNDROME	0.043926709999999994	1.7570683999999996
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.04386722	1.7546888
SLC39A8-CDG	0.04361595	1.7446380000000001
HYPERBILIVERDINEMIA; HBLVD	0.043498800000000004	1.7399520000000002
CLAPO SYNDROME	0.04344726	1.7378904
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.04344726	1.7378904
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.04344726	1.7378904
BETA-THALASSEMIA	0.04338838	1.7355351999999997
CONGENITAL ENTEROVIRUS INFECTION	0.0426304	1.705216
LEPRECHAUNISM	0.04257894	1.7031576
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.04238307	1.6953228
DOORS SYNDROME	0.04220189	1.6880756000000001
SSR4-CDG	0.04215154	1.6860616000000002
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.04209298	1.6837192
FETAL HYDANTOIN SYNDROME	0.04102532	1.6410128
AICARDI-GOUTIÈRES SYNDROME	0.04096977	1.6387908
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.04059248000000001	1.6236992000000001
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.04059248000000001	1.6236992000000001
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.04059248	1.6236992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.040165080000000006	1.6066032000000001
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.040165080000000006	1.6066032000000001
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03994565	1.5978260000000002
PORPHYRIA CUTANEA TARDA	0.03994565	1.5978260000000002
ADAMS-OLIVER SYNDROME 6; AOS6	0.0399225	1.5969
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.039394	1.57576
SENIOR-LOKEN SYNDROME 9	0.038888900000000004	1.5555560000000002
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.03886161	1.5544644
PULMONARY ARTERIAL HYPERTENSION	0.038740580000000004	1.5496232000000003
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.03866832	1.5467327999999998
RUBINSTEIN-TAYBI SYNDROME	0.03866832	1.5467327999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0384615	1.5384600000000002
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0384615	1.5384600000000002
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.0384615	1.5384600000000002
PHEOCHROMOCYTOMA	0.038405800000000004	1.5362320000000003
RUIJS-AALFS SYNDROME; RJALS	0.03774351	1.5097404
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.037320870000000006	1.4928348000000002
X-LINKED AGAMMAGLOBULINEMIA	0.037074899999999994	1.4829959999999998
BURKITT LYMPHOMA	0.037037	1.48148
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.037037	1.48148
BENIGN SCHWANNOMA	0.037037	1.48148
BLAU SYNDROME	0.037037	1.48148
NEONATAL ADRENOLEUKODYSTROPHY	0.037037	1.48148
TRISOMY 13	0.037037	1.48148
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	1.48148
CRANIOLENTICULOSUTURAL DYSPLASIA	0.037037	1.48148
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.48148
CRANIOLENTICULOSUTURAL DYSPLASIA	0.037037	1.48148
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.48148
POLAND SYNDROME	0.037037	1.48148
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.48148
SITOSTEROLEMIA	0.037037	1.48148
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.48148
ATRANSFERRINEMIA	0.037037	1.48148
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037037	1.48148
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.48148
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.037037	1.48148
RHYNS SYNDROME	0.037037	1.48148
JEUNE SYNDROME	0.037037	1.48148
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.037037	1.48148
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0353603	1.414412
SYSTEMIC MASTOCYTOSIS	0.03365503	1.3462012
NON-DISTAL MONOSOMY 20Q	0.03349199	1.3396796
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.033323	1.3329199999999999
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.033297639999999996	1.3319056
EDINBURGH MALFORMATION SYNDROME	0.03304096	1.3216384
TYROSINEMIA TYPE 1	0.03295358	1.3181432000000002
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.0326348	1.305392
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.032456399999999996	1.2982559999999999
TRICHOHEPATOENTERIC SYNDROME 1	0.03232909	1.2931636
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0322823	1.2912919999999999
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.03195145	1.278058
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.03191899	1.2767596
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.03166632	1.2666528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.03163764	1.2655056000000002
22Q11.2 DELETION SYNDROME	0.03135771	1.2543084
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.03128052	1.2512208
FAMILIAL COLORECTAL CANCER TYPE X	0.03125	1.25
ACUTE INTERMITTENT PORPHYRIA	0.03125	1.25
LYNCH SYNDROME	0.03125	1.25
CRI-DU-CHAT SYNDROME	0.03109796	1.2439184
TRICHOHEPATOENTERIC SYNDROME 2	0.030807429999999997	1.2322971999999999
GAUCHER DISEASE	0.030807429999999997	1.2322971999999999
MUCOPOLYSACCHARIDOSIS TYPE 7	0.030520719999999998	1.2208288
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.03041267	1.2165067999999999
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.030321360000000002	1.2128544
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.03026316	1.2105264
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.03022254	1.2089016
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0301601	1.206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0301601	1.206404
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.02997225	1.19889
OMODYSPLASIA 1; OMOD1	0.02994937	1.1979748000000001
CRANIOFACIOFRONTODIGITAL SYNDROME	0.029595769999999997	1.1838308
15Q13.3 MICRODELETION SYNDROME	0.02940912	1.1763648
LARSEN SYNDROME	0.02930625	1.17225
SILVER-RUSSELL SYNDROME	0.02922081	1.1688323999999999
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.02888095	1.155238
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.02878135	1.151254
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.0287149	1.148596
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.028697249999999997	1.1478899999999999
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.02869004	1.1476016
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.02853357	1.1413427999999999
CONGENITAL HYPOTHYROIDISM	0.02853357	1.1413427999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.02842466	1.1369864
SICKLE CELL ANEMIA	0.02824334	1.1297336
HEREDITARY SPHEROCYTOSIS	0.02824334	1.1297336
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.02810209	1.1240836
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.111112
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.111112
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.111112
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.111112
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.111112
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.111112
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.111112
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.111112
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.111112
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.111112
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.111112
CLEFT CHIN	0.027777800000000002	1.111112
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.111112
OROFACIAL CLEFT 3	0.027777800000000002	1.111112
NASAL BONES, ABSENCE OF	0.027777800000000002	1.111112
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.111112
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.111112
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.111112
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.111112
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.111112
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.111112
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.111112
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.111112
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.111112
DIMPLES, FACIAL	0.027777800000000002	1.111112
MENKES DISEASE	0.027777800000000002	1.111112
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.111112
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.111112
DWARFISM, LEVI TYPE	0.027777800000000002	1.111112
ARIMA SYNDROME	0.02771607	1.1086428
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.02771607	1.1086428
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.02761582	1.1046327999999999
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.02756362	1.1025448
RENPENNING SYNDROME 1; RENS1	0.027563619999999997	1.1025447999999998
WITTEVEEN-KOLK SYNDROME	0.027480370000000004	1.0992148000000002
GRISCELLI SYNDROME	0.027374939999999997	1.0949976
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.027374939999999997	1.0949976
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.02736425	1.0945699999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02706593	1.0826372
PROTEUS SYNDROME	0.02676423	1.0705692
NIEMANN-PICK DISEASE, TYPE A	0.02670358	1.0681432000000002
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.02670358	1.0681432000000002
NIEMANN-PICK DISEASE, TYPE C2	0.02670358	1.0681432000000002
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.02665715	1.066286
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.02653976	1.0615903999999998
SPHEROCYTOSIS, TYPE 1; SPH1	0.02653976	1.0615903999999998
HEMOGLOBIN--BETA LOCUS	0.02653976	1.0615903999999998
ALPHA-THALASSEMIA	0.02653976	1.0615903999999998
GLYCOGEN STORAGE DISEASE VII	0.02653976	1.0615903999999998
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02651375	1.06055
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.02626087	1.0504348000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.026255389999999997	1.0502155999999998
ADULT-ONSET STILL DISEASE	0.026033349999999997	1.0413339999999998
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.02601249	1.0404996
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.02584905	1.0339619999999998
LEGIONELLOSIS	0.025671359999999997	1.0268544
OCCIPITAL HORN SYNDROME	0.025671359999999997	1.0268544
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02559421	1.0237684
RING CHROMOSOME 12 SYNDROME	0.02542914	1.0171656
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.02542914	1.0171656
JUVENILE POLYPOSIS OF INFANCY	0.02542914	1.0171656
COFFIN-SIRIS SYNDROME 1; CSS1	0.02527267	1.0109068
BRANCHIO-OCULO-FACIAL SYNDROME	0.02516376	1.0065503999999998
PEROXISOME BIOGENESIS DISORDER 10B	0.025	1.0
CRIGLER-NAJJAR SYNDROME TYPE 2	0.025	1.0
GALACTOKINASE DEFICIENCY	0.025	1.0
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.025	1.0
MENKES DISEASE	0.025	1.0
ACUTE BILIRUBIN ENCEPHALOPATHY	0.025	1.0
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.025	1.0
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.025	1.0
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.025	1.0
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.025	1.0
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.025	1.0
POLYCYTHEMIA VERA	0.02495938	0.9983752
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02495938	0.9983752
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.02495938	0.9983752
WILLIAMS-BEUREN SYNDROME; WBS	0.02488712	0.9954847999999998
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.024624069999999998	0.9849627999999999
TRANSALDOLASE DEFICIENCY	0.02443389	0.9773555999999999
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.02443088	0.9772352
ACRORENAL-MANDIBULAR SYNDROME	0.024358619999999997	0.9743447999999998
MILLER-DIEKER SYNDROME	0.024358619999999997	0.9743447999999998
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.024329769999999997	0.9731907999999999
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.024329769999999997	0.9731907999999999
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0242244	0.9689760000000001
15Q24 MICRODELETION SYNDROME	0.02405571	0.9622284
VELO-FACIAL-SKELETAL SYNDROME	0.02405571	0.9622284
AMYLOIDOSIS, FAMILIAL VISCERAL	0.02392578	0.9570312000000001
AA AMYLOIDOSIS	0.02392578	0.9570312000000001
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.02370895	0.948358
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02370895	0.948358
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.023666589999999998	0.9466635999999998
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.023666589999999998	0.9466635999999998
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.02363344	0.9453376
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.02346347	0.9385388
KLIPPEL-TRÉNAUNAY SYNDROME	0.02344268	0.9377072
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.023426259999999997	0.9370503999999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.02339121	0.9356484
11Q22.2Q22.3 MICRODELETION SYNDROME	0.02337042	0.9348168
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02327859	0.9311436
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0232588	0.930352
CYSTINOSIS	0.0232558	0.930232
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0232558	0.930232
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	0.930232
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.02315569	0.9262276
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02309757	0.9239028
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.02291617	0.9166468000000001
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.02290792	0.9163167999999999
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.022830729999999997	0.9132291999999999
PSEUDOAMINOPTERIN SYNDROME	0.022747479999999997	0.9098991999999998
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.9090919999999999
FATCO SYNDROME	0.0227273	0.9090919999999999
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	0.9090919999999999
THUMB DEFORMITY	0.0227273	0.9090919999999999
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.9090919999999999
SIRENOMELIA	0.0227273	0.9090919999999999
BETHLEM MYOPATHY 1	0.0227273	0.9090919999999999
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.9090919999999999
WATSON SYNDROME	0.0227273	0.9090919999999999
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.9090919999999999
ARTERIES, ANOMALIES OF	0.0227273	0.9090919999999999
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.9090919999999999
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.9090919999999999
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.9090919999999999
COWDEN SYNDROME 6; CWS6	0.0227273	0.9090919999999999
COWDEN SYNDROME 5; CWS5	0.0227273	0.9090919999999999
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.9090919999999999
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.9090919999999999
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0227273	0.9090919999999999
AMYLOIDOSIS	0.0227273	0.9090919999999999
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.9090919999999999
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.9090919999999999
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.9090919999999999
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.9090919999999999
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.9090919999999999
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.9090919999999999
COCAINE EMBRYOFETOPATHY	0.0227273	0.9090919999999999
2Q31.1 MICRODELETION SYNDROME	0.022564149999999998	0.902566
3Q29 MICRODELETION SYNDROME	0.022424390000000002	0.8969756000000001
SECONDARY SHORT BOWEL SYNDROME	0.0222222	0.888888
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0222222	0.888888
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0222222	0.888888
JOHANSON-BLIZZARD SYNDROME; JBS	0.0222222	0.888888
CEREBROTENDINOUS XANTHOMATOSIS	0.0222222	0.888888
FUMARASE DEFICIENCY; FMRD	0.0222222	0.888888
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0222222	0.888888
AL AMYLOIDOSIS	0.022111779999999998	0.8844711999999999
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.022111779999999998	0.8844711999999999
AUTOSOMAL AGAMMAGLOBULINEMIA	0.022039519999999996	0.8815807999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.02203848	0.8815392
TIMOTHY SYNDROME; TS	0.02174815	0.869926
LYMPHATIC MALFORMATION 1	0.0217391	0.8695640000000001
BUSCHKE-OLLENDORFF SYNDROME	0.0217391	0.8695640000000001
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.0217391	0.8695640000000001
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.8695640000000001
GAPO SYNDROME	0.0217391	0.8695640000000001
MICROFORM HOLOPROSENCEPHALY	0.0217391	0.8695640000000001
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.0217391	0.8695640000000001
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0217391	0.8695640000000001
VERRUCOUS HEMANGIOMA	0.0217391	0.8695640000000001
LUMBAR SYNDROME	0.0217391	0.8695640000000001
NON-DISTAL TRISOMY 13Q	0.0217391	0.8695640000000001
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.0217391	0.8695640000000001
PTEN HAMARTOMA TUMOR SYNDROME	0.0217391	0.8695640000000001
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.0217391	0.8695640000000001
POEMS SYNDROME	0.0217391	0.8695640000000001
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.0217391	0.8695640000000001
COWDEN SYNDROME 7; CWS7	0.0217391	0.8695640000000001
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0217391	0.8695640000000001
PROTEUS-LIKE SYNDROME	0.0217391	0.8695640000000001
ENCHONDROMATOSIS, MULTIPLE	0.0217391	0.8695640000000001
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.8695640000000001
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0217391	0.8695640000000001
TEMPI SYNDROME	0.0217391	0.8695640000000001
WIEDEMANN-STEINER SYNDROME	0.02166278	0.8665111999999999
FIBROCHONDROGENESIS 1; FBCG1	0.02128485	0.8513940000000001
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.02128485	0.8513940000000001
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.02128485	0.8513940000000001
DIGEORGE SYNDROME; DGS	0.0212766	0.851064
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0212766	0.851064
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0212766	0.851064
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0212766	0.851064
MYOTONIC DYSTROPHY 1	0.0212766	0.851064
PANCREATIC COLIPASE DEFICIENCY	0.0212766	0.851064
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.02119941	0.8479763999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.02119941	0.8479763999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.02119941	0.8479763999999999
GABRIELE-DE VRIES SYNDROME	0.02111616	0.8446463999999999
CK SYNDROME	0.02107011	0.8428043999999999
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02107011	0.8428043999999999
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.02107011	0.8428043999999999
RENPENNING SYNDROME	0.02107011	0.8428043999999999
ATAXIA-TELANGIECTASIA	0.02058827	0.8235308
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.020408199999999998	0.8163279999999998
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.020408199999999998	0.8163279999999998
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	0.8163279999999998
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.020408199999999998	0.8163279999999998
LICHEN PLANOPILARIS	0.020408199999999998	0.8163279999999998
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.020408199999999998	0.8163279999999998
MYASTHENIA GRAVIS	0.020408199999999998	0.8163279999999998
RELAPSING POLYCHONDRITIS	0.020408199999999998	0.8163279999999998
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.020408199999999998	0.8163279999999998
219400 CYANOSIS AND HEPATIC DISEASE	0.020408199999999998	0.8163279999999998
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.02038076	0.8152304000000001
ATYPICAL WERNER SYNDROME	0.02033479	0.8133916
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.02030961	0.8123844
MONOSOMY 22	0.02025847	0.8103387999999999
GAUCHER DISEASE, PERINATAL LETHAL	0.020245290000000003	0.8098116000000001
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.020116679999999998	0.8046671999999999
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.020116679999999998	0.8046671999999999
CHROMOSOME 1P36 DELETION SYNDROME	0.01976188	0.7904751999999999
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01976188	0.7904751999999999
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.01976188	0.7904751999999999
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01974502	0.7898008
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01974502	0.7898008
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.01966257	0.7865028
MENTAL RETARDATION, X-LINKED 107; MRX107	0.01943879	0.7775516
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.01926396	0.7705584
CLASSICAL EHLERS-DANLOS SYNDROME	0.01911383	0.7645531999999999
TRISOMY 18	0.01911383	0.7645531999999999
CHARGE SYNDROME	0.01903058	0.7612231999999999
WOLCOTT-RALLISON SYNDROME	0.019013139999999998	0.7605255999999999
ZELLWEGER SYNDROME	0.018601669999999997	0.7440667999999999
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.01853052	0.7412208000000001
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.01853052	0.7412208000000001
BRAIN-LUNG-THYROID SYNDROME	0.01839594	0.7358376
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.01839594	0.7358376
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01839594	0.7358376
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.01839594	0.7358376
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.01837028	0.7348112
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.01837028	0.7348112
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.01837028	0.7348112
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.018298019999999998	0.7319207999999999
JOUBERT SYNDROME 1	0.018298019999999998	0.7319207999999999
GORLIN SYNDROME	0.018298019999999998	0.7319207999999999
20Q11.2 MICRODUPLICATION SYNDROME	0.01823735	0.729494
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01813056	0.7252223999999999
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01809162	0.7236648
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01809162	0.7236648
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01809162	0.7236648
PRIMARY LIPODYSTROPHY	0.01804144	0.7216576
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.01801084	0.7204336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.01800301	0.7201204
CHROMOSOME 10Q26 DELETION SYNDROME	0.01795975	0.71839
FEINGOLD SYNDROME 1; FGLDS1	0.01795975	0.71839
DISTAL MONOSOMY 10Q	0.01795975	0.71839
15Q26 OVERGROWTH SYNDROME	0.0179289	0.717156
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.01789869	0.7159476
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.01788038	0.7152152
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01773763	0.7095052000000001
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.01767335	0.7069340000000001
COG5-CDG	0.01767335	0.7069340000000001
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.01767335	0.7069340000000001
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.01764545	0.705818
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.01764545	0.705818
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.01756795	0.702718
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.01744182	0.6976728
RETICULOENDOTHELIOSIS, X-LINKED	0.01731136	0.6924544
LETTERER-SIWE DISEASE	0.01731136	0.6924544
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01731136	0.6924544
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.01731136	0.6924544
HYPERLIPOPROTEINEMIA, TYPE I	0.01731136	0.6924544
HURLER SYNDROME	0.01728535	0.6914140000000001
FOUNTAIN SYNDROME	0.01723227	0.6892908000000001
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.6666679999999999
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0166667	0.6666679999999999
THYMOMA, FAMILIAL	0.0166667	0.6666679999999999
CHYLOUS ASCITES	0.0166667	0.6666679999999999
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.6666679999999999
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.0166667	0.6666679999999999
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.6666679999999999
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.6666679999999999
AASE-SMITH SYNDROME	0.0166667	0.6666679999999999
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.6666679999999999
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.6666679999999999
BARDET-BIEDL SYNDROME	0.0166667	0.6666679999999999
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.6666679999999999
ANDROGEN INSENSITIVITY SYNDROME	0.0166667	0.6666679999999999
HOYERAAL-HREIDARSSON SYNDROME	0.0166667	0.6666679999999999
ICHTHYOSIS, X-LINKED	0.0166667	0.6666679999999999
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.6666679999999999
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.6666679999999999
NEPHRONOPHTHISIS 11; NPHP11	0.0166667	0.6666679999999999
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.6666679999999999
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.6666679999999999
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	0.6666679999999999
NASOPHARYNGEAL CARCINOMA	0.0166667	0.6666679999999999
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.6666679999999999
FADD-RELATED IMMUNODEFICIENCY	0.0166667	0.6666679999999999
ONCOCYTOMA	0.0166667	0.6666679999999999
ANTISYNTHETASE SYNDROME	0.0166667	0.6666679999999999
ADAMANTINOMA OF LONG BONES	0.0166667	0.6666679999999999
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.6666679999999999
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0166667	0.6666679999999999
TRIGEMINAL NEURALGIA	0.0166667	0.6666679999999999
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.6666679999999999
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0166667	0.6666679999999999
N SYNDROME	0.0166667	0.6666679999999999
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0166667	0.6666679999999999
PITYRIASIS RUBRA PILARIS	0.0166667	0.6666679999999999
117600 CEREBRAL SARCOMA	0.0166667	0.6666679999999999
HURIEZ SYNDROME; HRZ	0.0166667	0.6666679999999999
INTESTINAL LYMPHANGIECTASIA	0.0166667	0.6666679999999999
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0166667	0.6666679999999999
ACQUIRED PURPURA FULMINANS	0.0166667	0.6666679999999999
PORPHYRIA CUTANEA TARDA, TYPE I	0.0166667	0.6666679999999999
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0166667	0.6666679999999999
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.016491369999999998	0.6596547999999999
48,XXYY SYNDROME	0.016491369999999998	0.6596547999999999
TRANSKETOLASE DEFICIENCY	0.01640948	0.6563792
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.01633722	0.6534888
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01633722	0.6534888
HYPERTELORISM AND TETRALOGY OF FALLOT	0.01633722	0.6534888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.01619511	0.6478044
PYRUVATE DEHYDROGENASE DEFICIENCY	0.01604498	0.6417992
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01601413	0.6405652000000001
ADULT-ONSET NEMALINE MYOPATHY	0.01601413	0.6405652000000001
CHRISTIANSON SYNDROME	0.01601413	0.6405652000000001
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.01601413	0.6405652000000001
NEMALINE MYOPATHY 1; NEM1	0.01601413	0.6405652000000001
HARROD SYNDROME	0.01601413	0.6405652000000001
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.01601413	0.6405652000000001
NANCE-HORAN SYNDROME	0.01601413	0.6405652000000001
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.01601413	0.6405652000000001
BRANCHIOOTORENAL SYNDROME 1	0.01601413	0.6405652000000001
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.01601413	0.6405652000000001
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01601413	0.6405652000000001
FRAGILE X SYNDROME	0.01601413	0.6405652000000001
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01601413	0.6405652000000001
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.01601413	0.6405652000000001
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.01601413	0.6405652000000001
MARFAN SYNDROME; MFS	0.01601413	0.6405652000000001
SOTOS SYNDROME 2	0.01601413	0.6405652000000001
SECKEL SYNDROME 9; SCKL9	0.01601413	0.6405652000000001
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.01601413	0.6405652000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.01601413	0.6405652000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.01601413	0.6405652000000001
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.01596977	0.6387908
COG1-CDG	0.01573824	0.6295296
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.01573824	0.6295296
REYNOLDS SYNDROME	0.015662389999999998	0.6264955999999999
CHOLESTERYL ESTER STORAGE DISEASE	0.015662389999999998	0.6264955999999999
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.0156318	0.625272
SANDHOFF DISEASE	0.015581770000000002	0.6232708000000001
PETERS PLUS SYNDROME	0.01549204	0.6196815999999999
OCULOCEREBRORENAL SYNDROME OF LOWE	0.015299110000000001	0.6119644000000001
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.015299110000000001	0.6119644000000001
DESBUQUOIS DYSPLASIA 2; DBQD2	0.01525252	0.6101008
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.01525252	0.6101008
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.01525252	0.6101008
TETRASOMY 5P	0.0151685	0.60674
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.01508306	0.6033224
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.01508306	0.6033224
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.014970939999999999	0.5988376
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.014970939999999999	0.5988376
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.014970939999999999	0.5988376
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.014970939999999999	0.5988376
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.014970939999999999	0.5988376
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.014970939999999999	0.5988376
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.014970939999999999	0.5988376
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.014970939999999999	0.5988376
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.014970939999999999	0.5988376
TEMTAMY SYNDROME	0.01496896	0.5987584
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0149433	0.5977319999999999
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.0149433	0.5977319999999999
16Q24.3 MICRODELETION SYNDROME	0.0149433	0.5977319999999999
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0149433	0.5977319999999999
XFE PROGEROID SYNDROME; XFEPS	0.014910570000000001	0.5964228
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0147059	0.588236
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0147059	0.588236
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0147059	0.588236
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0147059	0.588236
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0147059	0.588236
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0147059	0.588236
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0147059	0.588236
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0147059	0.588236
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0147059	0.588236
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.0147059	0.588236
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.588236
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0147059	0.588236
TRICUSPID ATRESIA	0.0147059	0.588236
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0147059	0.588236
EVEN-PLUS SYNDROME	0.0147059	0.588236
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.588236
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0147059	0.588236
MONOSOMY 13Q34	0.01466715	0.5866859999999999
VISCERAL STEATOSIS, CONGENITAL	0.014608949999999999	0.5843579999999999
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.01453509	0.5814036
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01446093	0.5784372
ALLAN-HERNDON-DUDLEY SYNDROME	0.01441366	0.5765464
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.014320799999999998	0.5728319999999999
HEMOCHROMATOSIS, TYPE 2B	0.014320799999999998	0.5728319999999999
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.01400048	0.5600191999999999
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.013751780000000002	0.5500712000000001
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.013751780000000002	0.5500712000000001
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013751780000000002	0.5500712000000001
ACROCEPHALOPOLYDACTYLY	0.013679520000000002	0.5471808
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.0136212	0.544848
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0136212	0.544848
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.0136212	0.544848
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.0136212	0.544848
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0136212	0.544848
THORACOMELIC DYSPLASIA	0.0136212	0.544848
KOOLEN-DE VRIES SYNDROME	0.01361468	0.5445872
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.013545689999999999	0.5418276
KLEEFSTRA SYNDROME	0.01353718	0.5414872
KBG SYNDROME	0.01353576	0.5414304
DISTAL TRISOMY 18Q	0.01353576	0.5414304
KBG SYNDROME	0.01353576	0.5414304
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.01346025	0.53841
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.01345251	0.5381004
HYPERTRICHOSIS CUBITI	0.01345251	0.5381004
DISTAL MONOSOMY 15Q	0.01345174	0.5380696
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.013428269999999999	0.5371308
KLEEFSTRA SYNDROME	0.01336849	0.5347396
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.01334283	0.5337132
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.013267359999999999	0.5306943999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.013267359999999999	0.5306943999999999
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0132354	0.529416
16P11.2P12.2 MICRODELETION SYNDROME	0.0132354	0.529416
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01314996	0.5259984000000001
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01306671	0.5226684
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.01306671	0.5226684
APERT SYNDROME	0.012989210000000001	0.5195684
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.012989210000000001	0.5195684
CORNELIA DE LANGE SYNDROME 3	0.012989210000000001	0.5195684
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.012989210000000001	0.5195684
PFEIFFER SYNDROME	0.012989210000000001	0.5195684
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01290377	0.5161508
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01290377	0.5161508
BALLER-GEROLD SYNDROME	0.01262032	0.5048128000000001
SUMMITT SYNDROME	0.01262032	0.5048128000000001
DUBOWITZ SYNDROME	0.01262032	0.5048128000000001
22Q11.2 MICRODUPLICATION SYNDROME	0.01262032	0.5048128000000001
LATERAL MENINGOCELE SYNDROME	0.01262032	0.5048128000000001
HEMOCHROMATOSIS, TYPE 3; HFE3	0.012617219999999998	0.5046887999999999
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.01247447	0.4989788
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01247447	0.4989788
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.01220714	0.4882856
TRISOMY 20P	0.01209823	0.4839292
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.01209823	0.4839292
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01209823	0.4839292
MCLEOD SYNDROME; MCLDS	0.012048200000000002	0.481928
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.012048200000000002	0.481928
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.012048200000000002	0.481928
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.012048200000000002	0.481928
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.012048200000000002	0.481928
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.012048200000000002	0.481928
INTERMEDIATE OSTEOPETROSIS	0.012048200000000002	0.481928
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.012048200000000002	0.481928
ROIFMAN SYNDROME	0.012048200000000002	0.481928
KAPOSIFORM LYMPHANGIOMATOSIS	0.012048200000000002	0.481928
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.012048200000000002	0.481928
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.012048200000000002	0.481928
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.012048200000000002	0.481928
COG2-CDG	0.012048200000000002	0.481928
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.481928
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.012048200000000002	0.481928
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.012048200000000002	0.481928
TANGIER DISEASE	0.012048200000000002	0.481928
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.481928
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.481928
H SYNDROME	0.012048200000000002	0.481928
CHROMOSOME 17Q12 DELETION SYNDROME	0.01196315	0.47852600000000006
OROFACIODIGITAL SYNDROME TYPE 1	0.01196315	0.47852600000000006
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.011658400000000001	0.46633600000000003
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01163493	0.4653972
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01163493	0.4653972
DOWN SYNDROME	0.01163493	0.4653972
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.01163493	0.4653972
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01163493	0.4653972
SIMOSA CRANIOFACIAL SYNDROME	0.01160408	0.4641632
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01160408	0.4641632
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.01154949	0.46197960000000005
20Q13.33 MICRODELETION SYNDROME	0.01154949	0.46197960000000005
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.01151864	0.46074560000000003
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.01151864	0.46074560000000003
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.01151864	0.46074560000000003
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.01146624	0.45864960000000005
48,XXXY SYNDROME	0.01146624	0.45864960000000005
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.01143539	0.45741560000000003
2Q32Q33 MICRODELETION SYNDROME	0.01143539	0.45741560000000003
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.44197479999999995
CHANARIN-DORFMAN SYNDROME	0.01104937	0.44197479999999995
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01104937	0.44197479999999995
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.44197479999999995
DYSBETALIPOPROTEINEMIA	0.01104937	0.44197479999999995
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.01104937	0.44197479999999995
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.01104937	0.44197479999999995
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.44197479999999995
ODONTOCHONDRODYSPLASIA; ODCD	0.010989	0.43956000000000006
CRANIOACROFACIAL SYNDROME	0.010989	0.43956000000000006
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.010989	0.43956000000000006
BLOOM SYNDROME	0.010989	0.43956000000000006
BANGSTAD SYNDROME	0.010989	0.43956000000000006
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.010989	0.43956000000000006
OCULOFACIOCARDIODENTAL SYNDROME	0.010989	0.43956000000000006
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.010989	0.43956000000000006
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.010989	0.43956000000000006
SECKEL SYNDROME	0.010989	0.43956000000000006
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.010989	0.43956000000000006
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.010989	0.43956000000000006
TYPICAL NEMALINE MYOPATHY	0.010989	0.43956000000000006
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.010989	0.43956000000000006
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.010989	0.43956000000000006
WERNER SYNDROME	0.010989	0.43956000000000006
SHELDON-HALL SYNDROME	0.010989	0.43956000000000006
MARFAN SYNDROME	0.010989	0.43956000000000006
ACRO-RENAL-MANDIBULAR SYNDROME	0.010989	0.43956000000000006
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.010989	0.43956000000000006
SMITH-FINEMAN-MYERS SYNDROME	0.010989	0.43956000000000006
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010989	0.43956000000000006
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.010989	0.43956000000000006
1P36 DELETION SYNDROME	0.01097711	0.4390844
19P13.12 MICRODELETION SYNDROME	0.01097711	0.4390844
CONGENITAL TOXOPLASMOSIS	0.01088831	0.4355324
HEPATIC VENO-OCCLUSIVE DISEASE	0.01088831	0.4355324
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.01077089	0.43083560000000004
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.01077089	0.43083560000000004
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01077089	0.43083560000000004
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.01077089	0.43083560000000004
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.01077089	0.43083560000000004
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.01077089	0.43083560000000004
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.01077089	0.43083560000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.01077089	0.43083560000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01077089	0.43083560000000004
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.01057582	0.42303280000000004
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01057582	0.42303280000000004
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.01057582	0.42303280000000004
CHOPS SYNDROME; CHOPS	0.01057582	0.42303280000000004
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.01053936	0.42157439999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.01053936	0.42157439999999996
2Q37 MICRODELETION SYNDROME	0.01046691	0.4186764
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.01046691	0.4186764
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.010399229999999999	0.41596919999999993
CITRULLINEMIA, CLASSIC	0.010399229999999999	0.41596919999999993
DYSKERATOSIS CONGENITA	0.010399229999999999	0.41596919999999993
HEMOCHROMATOSIS, TYPE 2A	0.010399229999999999	0.41596919999999993
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.010399229999999999	0.41596919999999993
GALACTOSEMIA	0.010399229999999999	0.41596919999999993
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.01038289	0.4153156
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.01018422	0.4073688000000001
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.01011252	0.4045008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0101003	0.4040119999999999
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.0101003	0.4040119999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.01008111	0.40324440000000006
19P13.3 MICRODUPLICATION SYNDROME	0.01008111	0.40324440000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.01008111	0.40324440000000006
KOOLEN-DE VRIES SYNDROME; KDVS	0.01008111	0.40324440000000006
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.01002708	0.4010832000000001
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.01000361	0.40014439999999996
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.01000361	0.40014439999999996
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00994383	0.3977532000000001
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00991817	0.39672680000000005
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00991817	0.39672680000000005
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00991817	0.39672680000000005
HENNEKAM-BEEMER SYNDROME	0.00991817	0.39672680000000005
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00991817	0.39672680000000005
BENCZE SYNDROME	0.00983492	0.39339680000000005
EMANUEL SYNDROME	0.00983492	0.39339680000000005
DEAFNESS-CRANIOFACIAL SYNDROME	0.00983492	0.39339680000000005
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00934579	0.3738316
ADRENOMYODYSTROPHY	0.00934579	0.3738316
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.00934579	0.3738316
ACQUIRED PARTIAL LIPODYSTROPHY	0.00934579	0.3738316
300270 ADRENOMYODYSTROPHY	0.00934579	0.3738316
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.00934579	0.3738316
AROMATASE DEFICIENCY	0.00934579	0.3738316
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00934579	0.3738316
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.00934579	0.3738316
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	0.00934579	0.3738316
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00934579	0.3738316
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00934579	0.3738316
PATENT DUCTUS VENOSUS	0.00934579	0.3738316
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00934579	0.3738316
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00931519	0.3726076
MARBURG HEMORRHAGIC FEVER	0.00918473	0.3673892
RELAPSING FEVER	0.00918473	0.3673892
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00918473	0.3673892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00918473	0.3673892
COFFIN-SIRIS SYNDROME 6; CSS6	0.00885493	0.3541972
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.008796730000000001	0.35186920000000005
THYROID ECTOPIA	0.008796730000000001	0.35186920000000005
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.008796730000000001	0.35186920000000005
FAMILIAL THYROID DYSHORMONOGENESIS	0.008796730000000001	0.35186920000000005
THYROID HYPOPLASIA	0.008796730000000001	0.35186920000000005
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.008796730000000001	0.35186920000000005
THYROID HEMIAGENESIS	0.008796730000000001	0.35186920000000005
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.008796730000000001	0.35186920000000005
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.008796730000000001	0.35186920000000005
PERIPHERAL HYPOTHYROIDISM	0.008796730000000001	0.35186920000000005
PRIMARY CONGENITAL HYPOTHYROIDISM	0.008796730000000001	0.35186920000000005
CENTRAL CONGENITAL HYPOTHYROIDISM	0.008796730000000001	0.35186920000000005
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.008796730000000001	0.35186920000000005
PERMANENT CONGENITAL HYPOTHYROIDISM	0.008796730000000001	0.35186920000000005
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00874602	0.3498408
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00874602	0.3498408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00874602	0.3498408
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00874602	0.3498408
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00874602	0.3498408
HOLOPROSENCEPHALY	0.00874602	0.3498408
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00874583	0.34983319999999996
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00874583	0.34983319999999996
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.34782599999999997
SEA-BLUE HISTIOCYTE DISEASE	0.00869565	0.34782599999999997
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.34782599999999997
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.34782599999999997
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00869565	0.34782599999999997
CRYPTOCOCCOSIS	0.00869565	0.34782599999999997
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.00869565	0.34782599999999997
SCLERODERMA	0.00869565	0.34782599999999997
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.34782599999999997
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00867357	0.3469428
8Q21.11 MICRODELETION SYNDROME	0.00867357	0.3469428
AARSKOG-SCOTT SYNDROME	0.00867357	0.3469428
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00867357	0.3469428
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00867357	0.3469428
DISTAL MONOSOMY 1Q	0.00867357	0.3469428
MONOSOMY 5P	0.00867357	0.3469428
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00867357	0.3469428
6Q16 MICRODELETION SYNDROME	0.00867357	0.3469428
COHEN-GIBSON SYNDROME; COGIS	0.00867357	0.3469428
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00867357	0.3469428
WEAVER SYNDROME	0.00867357	0.3469428
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00867357	0.3469428
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00858955	0.343582
PALLISTER-KILLIAN SYNDROME	0.00858955	0.343582
SIFRIM-HITZ-WEISS SYNDROME	0.00858955	0.343582
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00858955	0.343582
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00858955	0.343582
SOMATOMAMMOTROPINOMA	0.0085587	0.34234800000000004
FRAGILE X MENTAL RETARDATION SYNDROME	0.0085587	0.34234800000000004
ACROMEGALY	0.0085587	0.34234800000000004
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0085587	0.34234800000000004
FRIED SYNDROME	0.0085587	0.34234800000000004
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0085587	0.34234800000000004
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.0085587	0.34234800000000004
SHUKLA-VERNON SYNDROME; SHUVER	0.0085587	0.34234800000000004
PETTIGREW SYNDROME	0.0085587	0.34234800000000004
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0085529	0.34211600000000003
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0085529	0.34211600000000003
BETA-KETOTHIOLASE DEFICIENCY	0.0085529	0.34211600000000003
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0085529	0.34211600000000003
PYRUVATE CARBOXYLASE DEFICIENCY	0.0085529	0.34211600000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.0085529	0.34211600000000003
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0085529	0.34211600000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.0085529	0.34211600000000003
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00844979	0.3379916
LELIS SYNDROME	0.00844979	0.3379916
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00844979	0.3379916
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00844979	0.3379916
HAREL-YOON SYNDROME; HAYOS	0.00844979	0.3379916
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00828253	0.33130119999999996
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00828253	0.33130119999999996
PEROXISOME BIOGENESIS DISORDER 3B	0.00828253	0.33130119999999996
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00821027	0.3284108
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00821027	0.3284108
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00821027	0.3284108
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.00821027	0.3284108
TRISOMY 12P	0.00821027	0.3284108
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00821027	0.3284108
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00821027	0.3284108
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00821027	0.3284108
VASCULAR EHLERS-DANLOS SYNDROME	0.00821027	0.3284108
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00821027	0.3284108
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00821027	0.3284108
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00821027	0.3284108
ICF SYNDROME	0.00821027	0.3284108
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00821027	0.3284108
HENNEKAM SYNDROME	0.00821027	0.3284108
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00821027	0.3284108
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00821027	0.3284108
ABRUZZO-ERICKSON SYNDROME	0.00821027	0.3284108
NOONAN SYNDROME	0.00819709	0.32788360000000005
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00812483	0.3249932
XQ12-Q13.3 DUPLICATION SYNDROME	0.00812483	0.3249932
DISTAL MONOSOMY 3P	0.00812483	0.3249932
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00812483	0.3249932
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00812483	0.3249932
AL KAISSI SYNDROME; ALKAS	0.00812483	0.3249932
LEGIUS SYNDROME	0.00812483	0.3249932
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00812483	0.3249932
CRANIOFACIAL DYSSYNOSTOSIS	0.00804158	0.3216632
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00804158	0.3216632
DUANE-RADIAL RAY SYNDROME; DRRS	0.00804158	0.3216632
SAETHRE-CHOTZEN SYNDROME	0.00804158	0.3216632
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00804158	0.3216632
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00804158	0.3216632
TETRASOMY 18P	0.00804158	0.3216632
LAMB-SHAFFER SYNDROME	0.00804158	0.3216632
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00804158	0.3216632
JACOBSEN SYNDROME	0.00804158	0.3216632
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00804158	0.3216632
OCULOECTODERMAL SYNDROME; OES	0.00804158	0.3216632
SRD5A3-CDG	0.0076116099999999996	0.3044644
ALG11-CDG	0.0076116099999999996	0.3044644
PITT-HOPKINS-LIKE SYNDROME	0.0076116099999999996	0.3044644
SLC35A2-CDG	0.0076116099999999996	0.3044644
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.007455140000000001	0.2982056
OROFACIODIGITAL SYNDROME TYPE 14	0.0071147	0.284588
SAY-BARBER-MILLER SYNDROME	0.0071147	0.284588
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0071147	0.284588
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0071147	0.284588
HOLOPROSENCEPHALY 5; HPE5	0.0071147	0.284588
MCDONOUGH SYNDROME	0.0071147	0.284588
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0071147	0.284588
VERVERI-BRADY SYNDROME; VERBRAS	0.0071147	0.284588
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0071147	0.284588
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0071147	0.284588
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.0071147	0.284588
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0071147	0.284588
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0071147	0.284588
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0071147	0.284588
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0071147	0.284588
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0071147	0.284588
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0071147	0.284588
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0071147	0.284588
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.00704225	0.28169
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00704225	0.28169
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00704225	0.28169
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00704225	0.28169
PARANA HARD SKIN SYNDROME	0.00704225	0.28169
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00704225	0.28169
FIBROCHONDROGENESIS	0.00704225	0.28169
2Q37 MONOSOMY	0.00704225	0.28169
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00704225	0.28169
ACROMICRIC DYSPLASIA	0.00704225	0.28169
RING CHROMOSOME 1 SYNDROME	0.00704225	0.28169
CUSHING SYNDROME	0.00704225	0.28169
DESBUQUOIS DYSPLASIA 1	0.00704225	0.28169
CHERUBISM	0.00704225	0.28169
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00704225	0.28169
MEHMO SYNDROME	0.00704225	0.28169
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00704225	0.28169
TRISOMY 4P	0.00704225	0.28169
SONODA SYNDROME	0.00704225	0.28169
FAMILIAL VISCERAL MYOPATHY	0.00704225	0.28169
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00704225	0.28169
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00704225	0.28169
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.00704225	0.28169
TRISOMY 5P	0.00704225	0.28169
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00704225	0.28169
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00704225	0.28169
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00704225	0.28169
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00704225	0.28169
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00704225	0.28169
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.28169
ACROMICRIC DYSPLASIA	0.00704225	0.28169
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00704225	0.28169
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.00704225	0.28169
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.00704225	0.28169
NEURALGIC AMYOTROPHY	0.00704225	0.28169
BARTH SYNDROME; BTHS	0.00704225	0.28169
CUSHING DISEASE	0.00704225	0.28169
HYPERTELORISM, TEEBI TYPE	0.00704225	0.28169
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00704225	0.28169
ACTH-DEPENDENT CUSHING SYNDROME	0.00704225	0.28169
JUNG SYNDROME	0.00704225	0.28169
WEAVER SYNDROME	0.00704225	0.28169
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00704225	0.28169
ACTH-INDEPENDENT CUSHING SYNDROME	0.00704225	0.28169
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00704225	0.28169
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00704225	0.28169
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00704225	0.28169
CHROMOSOME 18P DELETION SYNDROME	0.00704225	0.28169
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00704225	0.28169
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.00704225	0.28169
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00704225	0.28169
KNIEST DYSPLASIA	0.00704225	0.28169
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00704225	0.28169
DYSOSTEOSCLEROSIS	0.00704225	0.28169
BRACHYDACTYLY, TYPE E	0.00704225	0.28169
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00704225	0.28169
SHORT RIB-POLYDACTYLY SYNDROME	0.00704225	0.28169
GALACTOSEMIA	0.00696674	0.2786696
NIEMANN-PICK DISEASE TYPE C	0.00696674	0.2786696
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00696674	0.2786696
GRISCELLI SYNDROME TYPE 2	0.00696674	0.2786696
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00696674	0.2786696
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00696674	0.2786696
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.00696674	0.2786696
BABESIOSIS	0.00696674	0.2786696
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00696674	0.2786696
GALACTOSE EPIMERASE DEFICIENCY	0.00696674	0.2786696
CONGENITAL RUBELLA SYNDROME	0.00696674	0.2786696
GALACTOSE EPIMERASE DEFICIENCY	0.00696674	0.2786696
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.00696674	0.2786696
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00696674	0.2786696
PITT-HOPKINS SYNDROME	0.00695823	0.2783292
PITT-HOPKINS SYNDROME	0.00695823	0.2783292
TETRASOMY 12P	0.00695823	0.2783292
MICROTRIPLICATION 11Q24.1	0.00695823	0.2783292
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00695823	0.2783292
1Q41Q42 MICRODELETION SYNDROME	0.00695823	0.2783292
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00686847	0.2747388
INFANTILE SIALIC ACID STORAGE DISEASE	0.00686847	0.2747388
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00686847	0.2747388
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00686847	0.2747388
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00684932	0.27397279999999996
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00684932	0.27397279999999996
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.27397279999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.27397279999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.27397279999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.27397279999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00684932	0.27397279999999996
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00684932	0.27397279999999996
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00684932	0.27397279999999996
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00684932	0.27397279999999996
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00684932	0.27397279999999996
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.27397279999999996
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00684932	0.27397279999999996
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.27397279999999996
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00684932	0.27397279999999996
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00684932	0.27397279999999996
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00684932	0.27397279999999996
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00684932	0.27397279999999996
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00684932	0.27397279999999996
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00684932	0.27397279999999996
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00684932	0.27397279999999996
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00684932	0.27397279999999996
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00684932	0.27397279999999996
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00684932	0.27397279999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.00684932	0.27397279999999996
SALT-AND-PEPPER SYNDROME	0.00684932	0.27397279999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00684932	0.27397279999999996
AMISH INFANTILE EPILEPSY SYNDROME	0.00684932	0.27397279999999996
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.27397279999999996
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.27397279999999996
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00684932	0.27397279999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00684932	0.27397279999999996
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00684932	0.27397279999999996
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.27397279999999996
SENGERS SYNDROME	0.00684932	0.27397279999999996
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00684932	0.27397279999999996
MELAS	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00684932	0.27397279999999996
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.27397279999999996
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.27397279999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00684932	0.27397279999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00684932	0.27397279999999996
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00684932	0.27397279999999996
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00684932	0.27397279999999996
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00684932	0.27397279999999996
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00684932	0.27397279999999996
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00684932	0.27397279999999996
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.27397279999999996
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00684932	0.27397279999999996
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00684932	0.27397279999999996
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00684932	0.27397279999999996
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00684932	0.27397279999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.27397279999999996
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00684932	0.27397279999999996
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00684932	0.27397279999999996
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00684932	0.27397279999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00684932	0.27397279999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00684932	0.27397279999999996
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.27397279999999996
C SYNDROME	0.0067595599999999995	0.27038239999999997
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0067595599999999995	0.27038239999999997
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0066564499999999995	0.266258
OROFACIODIGITAL SYNDROME TYPE 6	0.0066564499999999995	0.266258
RING CHROMOSOME 22 SYNDROME	0.0066564499999999995	0.266258
19P13.13 MICRODELETION SYNDROME	0.0066564499999999995	0.266258
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0066564499999999995	0.266258
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0066564499999999995	0.266258
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0066564499999999995	0.266258
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0066564499999999995	0.266258
MAN1B1-CDG	0.0066564499999999995	0.266258
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00657895	0.263158
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00657895	0.263158
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00657895	0.263158
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00657895	0.263158
ACHONDROGENESIS TYPE 1B	0.00657895	0.263158
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00657895	0.263158
DYSOSTOSIS, STANESCU TYPE	0.00657895	0.263158
KYPHOMELIC DYSPLASIA	0.00657895	0.263158
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00657895	0.263158
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00657895	0.263158
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00657895	0.263158
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00657895	0.263158
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00657895	0.263158
LETHAL KNIEST-LIKE DYSPLASIA	0.00657895	0.263158
ROBINOW-SORAUF SYNDROME	0.00657895	0.263158
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00657895	0.263158
MAXILLONASAL DYSPLASIA	0.00657895	0.263158
KYPHOMELIC DYSPLASIA	0.00657895	0.263158
THANATOPHORIC DYSPLASIA TYPE 1	0.00657895	0.263158
MARSHALL SYNDROME	0.00657895	0.263158
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00657895	0.263158
ACHONDROGENESIS	0.00657895	0.263158
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00657895	0.263158
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00657895	0.263158
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00657895	0.263158
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00657895	0.263158
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00657895	0.263158
EMERY-NELSON SYNDROME	0.00657895	0.263158
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00657895	0.263158
THANATOPHORIC DYSPLASIA	0.00657895	0.263158
SCHWARTZ-JAMPEL SYNDROME	0.00657895	0.263158
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00657895	0.263158
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00657895	0.263158
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00657895	0.263158
AL-RAQAD SYNDROME; ARS	0.00657895	0.263158
ACHONDROGENESIS TYPE 2	0.00657895	0.263158
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.00657895	0.263158
LARSEN-LIKE SYNDROME	0.00657895	0.263158
KNIEST-LIKE DYSPLASIA, LETHAL	0.00657895	0.263158
CAMPOMELIC DYSPLASIA	0.00657895	0.263158
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00657895	0.263158
ACHONDROGENESIS TYPE 1A	0.00657895	0.263158
OROFACIODIGITAL SYNDROME TYPE 10	0.00657895	0.263158
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00657895	0.263158
THANATOPHORIC DYSPLASIA TYPE 2	0.00657895	0.263158
OROFACIODIGITAL SYNDROME XV; OFD15	0.00657895	0.263158
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00657895	0.263158
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00657895	0.263158
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00657895	0.263158
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00657895	0.263158
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00649351	0.25974040000000004
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00649351	0.25974040000000004
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00649351	0.25974040000000004
SHORT STATURE, BRUSSELS TYPE	0.00649351	0.25974040000000004
3Q27.3 MICRODELETION SYNDROME	0.00649351	0.25974040000000004
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.00649351	0.25974040000000004
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00649351	0.25974040000000004
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00649351	0.25974040000000004
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00649351	0.25974040000000004
12Q14 MICRODELETION SYNDROME	0.00649351	0.25974040000000004
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00649351	0.25974040000000004
FLOATING-HARBOR SYNDROME	0.00649351	0.25974040000000004
MESOMELIA-SYNOSTOSES SYNDROME	0.00649351	0.25974040000000004
CREE MENTAL RETARDATION SYNDROME	0.00649351	0.25974040000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.00649351	0.25974040000000004
RUSSELL-SILVER SYNDROME, X-LINKED	0.00649351	0.25974040000000004
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00649351	0.25974040000000004
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00649351	0.25974040000000004
SHORT SYNDROME	0.00649351	0.25974040000000004
MEVALONIC ACIDURIA	0.00649351	0.25974040000000004
3-HYDROXYISOBUTYRIC ACIDURIA	0.00649351	0.25974040000000004
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00649351	0.25974040000000004
WOODHOUSE-SAKATI SYNDROME	0.00649351	0.25974040000000004
MEIER-GORLIN SYNDROME 3; MGORS3	0.00649351	0.25974040000000004
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00649351	0.25974040000000004
MEIER-GORLIN SYNDROME 5; MGORS5	0.00649351	0.25974040000000004
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00649351	0.25974040000000004
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00649351	0.25974040000000004
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00649351	0.25974040000000004
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00649351	0.25974040000000004
OSTEOGENESIS IMPERFECTA, TYPE X	0.00649351	0.25974040000000004
17Q24.2 MICRODELETION SYNDROME	0.00649351	0.25974040000000004
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00649351	0.25974040000000004
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00649351	0.25974040000000004
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00649351	0.25974040000000004
FLOATING-HARBOR SYNDROME	0.00649351	0.25974040000000004
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00649351	0.25974040000000004
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00649351	0.25974040000000004
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00649351	0.25974040000000004
BRUCK SYNDROME	0.00649351	0.25974040000000004
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00649351	0.25974040000000004
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00649351	0.25974040000000004
17P11.2 MICRODUPLICATION SYNDROME	0.00649351	0.25974040000000004
POPOV-CHANG SYNDROME; POPCHAS	0.00649351	0.25974040000000004
WOODHOUSE-SAKATI SYNDROME	0.00649351	0.25974040000000004
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00649351	0.25974040000000004
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00649351	0.25974040000000004
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00649351	0.25974040000000004
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00649351	0.25974040000000004
3M SYNDROME	0.00649351	0.25974040000000004
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00649351	0.25974040000000004
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00649351	0.25974040000000004
FONTAINE PROGEROID SYNDROME; FPS	0.00649351	0.25974040000000004
SHORT SYNDROME	0.00649351	0.25974040000000004
PARTINGTON SYNDROME	0.00649351	0.25974040000000004
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00649351	0.25974040000000004
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.00649351	0.25974040000000004
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00649351	0.25974040000000004
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00649351	0.25974040000000004
OSTEOGENESIS IMPERFECTA, TYPE V	0.00649351	0.25974040000000004
THREE M SYNDROME 2; 3M2	0.00649351	0.25974040000000004
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00649351	0.25974040000000004
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00649351	0.25974040000000004
OCULOCEREBROCUTANEOUS SYNDROME	0.00641026	0.25641040000000004
MELNICK-NEEDLES SYNDROME	0.00641026	0.25641040000000004
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00641026	0.25641040000000004
DUANE RETRACTION SYNDROME	0.00641026	0.25641040000000004
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00641026	0.25641040000000004
WILDERVANCK SYNDROME	0.00641026	0.25641040000000004
JOHNSON NEUROECTODERMAL SYNDROME	0.00641026	0.25641040000000004
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00641026	0.25641040000000004
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	0.25641040000000004
GOLDENHAR SYNDROME	0.00641026	0.25641040000000004
SECKEL SYNDROME 1; SCKL1	0.00641026	0.25641040000000004
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00641026	0.25641040000000004
ISOLATED PLAGIOCEPHALY	0.00641026	0.25641040000000004
OCULOAURICULOFRONTONASAL SYNDROME	0.00641026	0.25641040000000004
CURRY-JONES SYNDROME	0.00641026	0.25641040000000004
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00641026	0.25641040000000004
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00641026	0.25641040000000004
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00641026	0.25641040000000004
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00641026	0.25641040000000004
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00641026	0.25641040000000004
WILDERVANCK SYNDROME	0.00641026	0.25641040000000004
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	0.25641040000000004
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	0.25641040000000004
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	0.25641040000000004
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00641026	0.25641040000000004
TOWNES-BROCKS SYNDROME	0.00641026	0.25641040000000004
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00641026	0.25641040000000004
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00641026	0.25641040000000004
OTOFACIOCERVICAL SYNDROME	0.00641026	0.25641040000000004
MULTIPLE SYNOSTOSES SYNDROME	0.00641026	0.25641040000000004
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00641026	0.25641040000000004
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00641026	0.25641040000000004
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00641026	0.25641040000000004
ELSAHY-WATERS SYNDROME; ESWS	0.00641026	0.25641040000000004
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	0.25641040000000004
TRIOPIA	0.00641026	0.25641040000000004
FOCAL DERMAL HYPOPLASIA; FDH	0.00641026	0.25641040000000004
ZTTK SYNDROME; ZTTKS	0.00641026	0.25641040000000004
TORTICOLLIS	0.00641026	0.25641040000000004
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00641026	0.25641040000000004
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	0.25641040000000004
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00641026	0.25641040000000004
ISOLATED KLIPPEL-FEIL SYNDROME	0.00641026	0.25641040000000004
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00641026	0.25641040000000004
CRANIOFRONTONASAL SYNDROME; CFNS	0.00641026	0.25641040000000004
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00641026	0.25641040000000004
HEMIFACIAL HYPERPLASIA	0.00641026	0.25641040000000004
GORDON SYNDROME	0.00641026	0.25641040000000004
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	0.25641040000000004
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00641026	0.25641040000000004
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00641026	0.25641040000000004
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00641026	0.25641040000000004
OTOMANDIBULAR SYNDROME	0.00641026	0.25641040000000004
SCLEROSTEOSIS 2; SOST2	0.00641026	0.25641040000000004
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	0.25641040000000004
DISTAL TRISOMY 15Q	0.00641026	0.25641040000000004
DEAFNESS-CRANIOFACIAL SYNDROME	0.00641026	0.25641040000000004
CONGENITAL HYDROCEPHALUS	0.00641026	0.25641040000000004
FOCAL DERMAL HYPOPLASIA	0.00641026	0.25641040000000004
BRANCHIOOTIC SYNDROME	0.00641026	0.25641040000000004
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00641026	0.25641040000000004
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00641026	0.25641040000000004
CURRY-JONES SYNDROME	0.00641026	0.25641040000000004
ISOLATED HEMIHYPERPLASIA	0.00641026	0.25641040000000004
SPINOCEREBELLAR ATAXIA TYPE 34	0.00641026	0.25641040000000004
CRANIOFRONTONASAL DYSPLASIA	0.00641026	0.25641040000000004
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.00641026	0.25641040000000004
CAFFEY DISEASE	0.00641026	0.25641040000000004
WYBURN-MASON SYNDROME	0.00641026	0.25641040000000004
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00641026	0.25641040000000004
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	0.25641040000000004
AURICULOCONDYLAR SYNDROME	0.00641026	0.25641040000000004
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00641026	0.25641040000000004
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00641026	0.25641040000000004
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00641026	0.25641040000000004
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00562515	0.22500599999999998
RETINITIS PIGMENTOSA 59; RP59	0.00562515	0.22500599999999998
NEUROENDOCRINE TUMOR OF STOMACH	0.00562515	0.22500599999999998
GLYCOGEN STORAGE DISEASE IXA	0.00562515	0.22500599999999998
PSEUDO-TORCH SYNDROME 2	0.00562515	0.22500599999999998
LEISHMANIASIS	0.00562515	0.22500599999999998
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00562515	0.22500599999999998
CHOREOACANTHOCYTOSIS	0.00562515	0.22500599999999998
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00562515	0.22500599999999998
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00562515	0.22500599999999998
NEONATAL LUPUS ERYTHEMATOSUS	0.00562515	0.22500599999999998
NEUROENDOCRINE TUMOR OF THE COLON	0.00562515	0.22500599999999998
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00562515	0.22500599999999998
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00562515	0.22500599999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00562515	0.22500599999999998
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00562515	0.22500599999999998
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00562515	0.22500599999999998
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00562515	0.22500599999999998
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00562515	0.22500599999999998
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00562515	0.22500599999999998
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00562515	0.22500599999999998
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00562515	0.22500599999999998
CLASSIC HOMOCYSTINURIA	0.00562515	0.22500599999999998
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00562515	0.22500599999999998
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00562515	0.22500599999999998
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0055528899999999996	0.22211559999999997
PROLIDASE DEFICIENCY	0.00539362	0.21574480000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00539362	0.21574480000000001
FREE SIALIC ACID STORAGE DISEASE	0.00539362	0.21574480000000001
SÉZARY SYNDROME	0.00539362	0.21574480000000001
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00539362	0.21574480000000001
CAMURATI-ENGELMANN DISEASE	0.00539362	0.21574480000000001
MEGAEPIPHYSEAL DWARFISM	0.00532136	0.2128544
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.00532136	0.2128544
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00532136	0.2128544
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00532136	0.2128544
SHPRINTZEN OMPHALOCELE SYNDROME	0.00532136	0.2128544
MILROY DISEASE	0.00532136	0.2128544
49,XXXYY SYNDROME	0.00532136	0.2128544
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00532136	0.2128544
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00532136	0.2128544
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00532136	0.2128544
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00532136	0.2128544
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00532136	0.2128544
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00532136	0.2128544
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00532136	0.2128544
CEREBROFACIOARTICULAR SYNDROME	0.00532136	0.2128544
MATERNAL PHENYLKETONURIA	0.00532136	0.2128544
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00532136	0.2128544
NOONAN SYNDROME 5; NS5	0.00532136	0.2128544
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00532136	0.2128544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00532136	0.2128544
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00532136	0.2128544
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.00532136	0.2128544
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00532136	0.2128544
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00532136	0.2128544
HOLMES-GANG SYNDROME	0.00532136	0.2128544
MONOSOMY 18Q	0.00532136	0.2128544
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00532136	0.2128544
DUPLICATION/INVERSION 15Q11	0.00532136	0.2128544
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00532136	0.2128544
LICHTENSTEIN SYNDROME	0.00532136	0.2128544
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00532136	0.2128544
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00532136	0.2128544
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00532136	0.2128544
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00532136	0.2128544
CONGENITAL PANCREATIC CYST	0.00526316	0.2105264
DOMINANT BETA-THALASSEMIA	0.00526316	0.2105264
ACETAMINOPHEN METABOLISM	0.00526316	0.2105264
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.00526316	0.2105264
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00526316	0.2105264
224250 DYSMYELINATION WITH JAUNDICE	0.00526316	0.2105264
CRIGLER-NAJJAR SYNDROME, TYPE II	0.00526316	0.2105264
PANCREATOBLASTOMA	0.00526316	0.2105264
ACTH DEFICIENCY, ISOLATED; IAD	0.00526316	0.2105264
CLASSIC GALACTOSEMIA	0.00526316	0.2105264
HEREDITARY CHRONIC PANCREATITIS	0.00526316	0.2105264
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.00526316	0.2105264
SPECTRIN, BETA, ERYTHROCYTIC	0.00526316	0.2105264
ELLIPTOCYTOSIS 1; EL1	0.00526316	0.2105264
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.00526316	0.2105264
CASTLEMAN DISEASE	0.00526316	0.2105264
RH-NULL, REGULATOR TYPE; RHNR	0.00526316	0.2105264
FAMILIAL ATRIAL MYXOMA	0.00526316	0.2105264
ROTOR SYNDROME	0.00526316	0.2105264
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00526316	0.2105264
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.00526316	0.2105264
YELLOW FEVER	0.00526316	0.2105264
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00526316	0.2105264
GILBERT SYNDROME	0.00526316	0.2105264
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.00526316	0.2105264
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00526316	0.2105264
SPHEROCYTOSIS, TYPE 2	0.00526316	0.2105264
CRIGLER-NAJJAR SYNDROME	0.00526316	0.2105264
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00526316	0.2105264
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.00526316	0.2105264
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.00526316	0.2105264
EVANS SYNDROME	0.00526316	0.2105264
HYPERBILIRUBINEMIA, ROTOR TYPE	0.00526316	0.2105264
RIFT VALLEY FEVER	0.00526316	0.2105264
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00526316	0.2105264
NEURAMINIDASE DEFICIENCY	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00523715	0.209486
SIALIDOSIS TYPE 2	0.00523715	0.209486
MULTIPLE SULFATASE DEFICIENCY	0.00523715	0.209486
MORQUIO SYNDROME A	0.00523715	0.209486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00523715	0.209486
HURLER-SCHEIE SYNDROME	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00523715	0.209486
PACHYDERMOPERIOSTOSIS	0.00523715	0.209486
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00523715	0.209486
CAMPOMELIA, CUMMING TYPE	0.00523715	0.209486
ACROOSTEOLYSIS DOMINANT TYPE	0.00523715	0.209486
ZIMMERMANN-LABAND SYNDROME 1	0.00523715	0.209486
ALPHA-MANNOSIDOSIS	0.00523715	0.209486
SCHEIE SYNDROME	0.00523715	0.209486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00523715	0.209486
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00516489	0.2065956
COFFIN-SIRIS SYNDROME	0.00516489	0.2065956
OGDEN SYNDROME; OGDNS	0.00516489	0.2065956
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00516489	0.2065956
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00516489	0.2065956
COFFIN-LOWRY SYNDROME	0.00516489	0.2065956
X SMALL RINGS	0.00516489	0.2065956
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00516489	0.2065956
COSTELLO SYNDROME; CSTLO	0.00516489	0.2065956
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00516489	0.2065956
TEMPLE-BARAITSER SYNDROME	0.00516489	0.2065956
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00516489	0.2065956
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00516489	0.2065956
AREDYLD SYNDROME	0.00512824	0.20512960000000002
DISTAL MONOSOMY 17Q	0.00512824	0.20512960000000002
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00512824	0.20512960000000002
URBAN-ROGERS-MEYER SYNDROME	0.00505598	0.2022392
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00505598	0.2022392
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00505598	0.2022392
NON-DISTAL MONOSOMY 10Q	0.00505598	0.2022392
1Q44 MICRODELETION SYNDROME	0.00505598	0.2022392
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00505598	0.2022392
OROFACIAL CLEFT 15	0.00505598	0.2022392
SCHOLTE SYNDROME; SHLTS	0.00505598	0.2022392
DISTAL MONOSOMY 9P	0.00505598	0.2022392
MONOSOMY 9P	0.00505598	0.2022392
49,XXXXY SYNDROME	0.00505598	0.2022392
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00505598	0.2022392
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00505598	0.2022392
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00505598	0.2022392
TRISOMY X	0.00505598	0.2022392
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00505598	0.2022392
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00505598	0.2022392
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00505598	0.2022392
6Q25 MICRODELETION SYNDROME	0.00505598	0.2022392
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00505598	0.2022392
TETRASOMY X	0.00505598	0.2022392
OCULODENTODIGITAL DYSPLASIA	0.00505598	0.2022392
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00505598	0.2022392
10Q22.3Q23.3 MICRODELETION SYNDROME	0.00505598	0.2022392
CHIME SYNDROME	0.00505598	0.2022392
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00505598	0.2022392
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00505598	0.2022392
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00505598	0.2022392
CHROMOSOME 9P DELETION SYNDROME	0.00505598	0.2022392
CHROMOSOME 16Q22 DELETION SYNDROME	0.00505598	0.2022392
8P23.1 MICRODELETION SYNDROME	0.00505598	0.2022392
8P11.2 DELETION SYNDROME	0.00505598	0.2022392
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00505598	0.2022392
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00505598	0.2022392
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00505598	0.2022392
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00502513	0.2010052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00502513	0.2010052
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00502513	0.2010052
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00502513	0.2010052
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00502513	0.2010052
OTOFACIOCERVICAL SYNDROME	0.00502513	0.2010052
ARTERIAL TORTUOSITY SYNDROME	0.00502513	0.2010052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00502513	0.2010052
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00502513	0.2010052
CEDNIK SYNDROME	0.00502513	0.2010052
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00502513	0.2010052
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.00502513	0.2010052
JOUBERT SYNDROME WITH RENAL DEFECT	0.00502513	0.2010052
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00502513	0.2010052
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00502513	0.2010052
KEUTEL SYNDROME	0.00502513	0.2010052
OTODENTAL DYSPLASIA	0.00502513	0.2010052
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00502513	0.2010052
MARFANOID HABITUS WITH SITUS INVERSUS	0.00502513	0.2010052
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00502513	0.2010052
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00502513	0.2010052
CAP MYOPATHY	0.00502513	0.2010052
MENTAL RETARDATION, X-LINKED 93	0.00502513	0.2010052
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00502513	0.2010052
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00502513	0.2010052
GLASS SYNDROME	0.00502513	0.2010052
MENTAL RETARDATION, X-LINKED 72	0.00502513	0.2010052
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00502513	0.2010052
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00502513	0.2010052
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00502513	0.2010052
NANCE-HORAN SYNDROME	0.00502513	0.2010052
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00502513	0.2010052
15Q14 MICRODELETION SYNDROME	0.00502513	0.2010052
DISTAL MONOSOMY 19P13.3	0.00502513	0.2010052
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00502513	0.2010052
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00502513	0.2010052
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00502513	0.2010052
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00502513	0.2010052
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.00502513	0.2010052
MOSAIC TRISOMY 8	0.00502513	0.2010052
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00502513	0.2010052
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00502513	0.2010052
MEHMO SYNDROME; MEHMO	0.00502513	0.2010052
TEMTAMY SYNDROME; TEMTYS	0.00502513	0.2010052
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00502513	0.2010052
TURNPENNY-FRY SYNDROME; TPFS	0.00502513	0.2010052
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00502513	0.2010052
JOUBERT SYNDROME	0.00502513	0.2010052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00502513	0.2010052
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00502513	0.2010052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00502513	0.2010052
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00502513	0.2010052
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00502513	0.2010052
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00502513	0.2010052
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00502513	0.2010052
MENTAL RETARDATION, X-LINKED 101; MRX101	0.00502513	0.2010052
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00502513	0.2010052
SOTOS SYNDROME 3	0.00502513	0.2010052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502513	0.2010052
RAPADILINO SYNDROME	0.00502513	0.2010052
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00502513	0.2010052
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00502513	0.2010052
SHASHI-PENA SYNDROME; SHAPNS	0.00502513	0.2010052
CHROMOSOME 1P35 DELETION SYNDROME	0.00502513	0.2010052
CONGENITAL MYASTHENIC SYNDROME	0.00502513	0.2010052
OTODENTAL SYNDROME	0.00502513	0.2010052
POLYVALVULAR HEART DISEASE SYNDROME	0.00502513	0.2010052
ARTERIAL TORTUOSITY SYNDROME	0.00502513	0.2010052
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00502513	0.2010052
KEUTEL SYNDROME; KTLS	0.00502513	0.2010052
LUSCAN-LUMISH SYNDROME; LLS	0.00502513	0.2010052
19Q13.11 MICRODELETION SYNDROME	0.00502513	0.2010052
AU-KLINE SYNDROME; AUKS	0.00502513	0.2010052
LOEYS-DIETZ SYNDROME 3; LDS3	0.00502513	0.2010052
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00502513	0.2010052
CONGENITAL DISORDER OF GLYCOSYLATION	0.00392157	0.1568628
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.00392157	0.1568628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00392157	0.1568628
BECKER MUSCULAR DYSTROPHY	0.00392157	0.1568628
TOXIC EPIDERMAL NECROLYSIS	0.00392157	0.1568628
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00392157	0.1568628
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00392157	0.1568628
COG8-CDG	0.00392157	0.1568628
NEUROLEPTIC MALIGNANT SYNDROME	0.00392157	0.1568628
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.1568628
RETINITIS PIGMENTOSA 71; RP71	0.00392157	0.1568628
BARDET-BIEDL SYNDROME 21; BBS21	0.00392157	0.1568628
CHRONIC GRAFT VERSUS HOST DISEASE	0.00392157	0.1568628
PREECLAMPSIA/ECLAMPSIA 1	0.00392157	0.1568628
MYH9-RELATED DISEASE	0.00392157	0.1568628
DPM3-CDG	0.00392157	0.1568628
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00392157	0.1568628
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.1568628
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.1568628
MEDULLOBLASTOMA	0.00392157	0.1568628
STEVENS-JOHNSON SYNDROME	0.00392157	0.1568628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.1568628
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00392157	0.1568628
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.1568628
PRIMARY HYPEROXALURIA	0.00392157	0.1568628
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00392157	0.1568628
HELLP SYNDROME	0.00392157	0.1568628
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.00392157	0.1568628
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.1568628
17Q12 MICRODELETION SYNDROME	0.00392157	0.1568628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.00392157	0.1568628
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.1476016
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00369004	0.1476016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00369004	0.1476016
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.1476016
HAIRY ELBOWS	0.00369004	0.1476016
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00369004	0.1476016
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.1476016
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.1476016
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00369004	0.1476016
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00369004	0.1476016
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00369004	0.1476016
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00369004	0.1476016
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.1476016
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00369004	0.1476016
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.1476016
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00369004	0.1476016
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00369004	0.1476016
BETA-MANNOSIDOSIS	0.00369004	0.1476016
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00369004	0.1476016
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.1476016
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.1476016
601095 HARROD SYNDROME	0.00369004	0.1476016
RIDDLE SYNDROME	0.00369004	0.1476016
NEPHROSIALIDOSIS	0.00369004	0.1476016
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00369004	0.1476016
6Q TERMINAL DELETION SYNDROME	0.00369004	0.1476016
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00369004	0.1476016
CONO-SPONDYLAR DYSPLASIA	0.00369004	0.1476016
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00369004	0.1476016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00369004	0.1476016
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00369004	0.1476016
WAARDENBURG SYNDROME	0.00369004	0.1476016
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00369004	0.1476016
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00369004	0.1476016
WILSON-TURNER SYNDROME	0.00369004	0.1476016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.1476016
ESOPHAGEAL ATRESIA	0.00369004	0.1476016
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00369004	0.1476016
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.1476016
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00369004	0.1476016
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00369004	0.1476016
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00369004	0.1476016
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.1476016
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00369004	0.1476016
EPIDERMAL NEVUS SYNDROME	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00369004	0.1476016
PRADER-WILLI SYNDROME	0.00369004	0.1476016
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00369004	0.1476016
LARON SYNDROME	0.00369004	0.1476016
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00369004	0.1476016
ZECHI-CEIDE SYNDROME	0.00369004	0.1476016
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00369004	0.1476016
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.1476016
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00369004	0.1476016
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00369004	0.1476016
RODRIGUES BLINDNESS	0.00369004	0.1476016
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.1476016
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.1476016
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.00369004	0.1476016
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.1476016
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00369004	0.1476016
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.1476016
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.1476016
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00369004	0.1476016
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.1476016
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00369004	0.1476016
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00369004	0.1476016
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00369004	0.1476016
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.1476016
UNILATERAL POLYMICROGYRIA	0.00369004	0.1476016
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.1476016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00369004	0.1476016
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00369004	0.1476016
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00369004	0.1476016
ROIFMAN-CHITAYAT SYNDROME	0.00369004	0.1476016
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.1476016
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.1476016
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00369004	0.1476016
EPILEPSY-TELANGIECTASIA	0.00369004	0.1476016
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.1476016
ENDOCARDIAL FIBROELASTOSIS	0.00369004	0.1476016
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00369004	0.1476016
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.1476016
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00369004	0.1476016
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.1476016
GLYCEROL KINASE DEFICIENCY; GKD	0.00369004	0.1476016
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00369004	0.1476016
CROUZON DISEASE	0.00369004	0.1476016
16P13.2 MICRODELETION SYNDROME	0.00369004	0.1476016
KLEEFSTRA SYNDROME 2; KLEFS2	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00369004	0.1476016
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.1476016
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.1476016
UROFACIAL SYNDROME	0.00369004	0.1476016
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.1476016
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00369004	0.1476016
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.1476016
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00369004	0.1476016
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00369004	0.1476016
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.1476016
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00369004	0.1476016
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.1476016
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00369004	0.1476016
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00369004	0.1476016
PGM3-CDG	0.00369004	0.1476016
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.1476016
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.1476016
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00369004	0.1476016
SPINOCEREBELLAR ATAXIA TYPE 13	0.00369004	0.1476016
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00369004	0.1476016
CHROMOSOME 16P13.2 DELETION SYNDROME	0.00369004	0.1476016
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.00369004	0.1476016
MENTAL RETARDATION, X-LINKED 102	0.00369004	0.1476016
11P15.4 MICRODUPLICATION SYNDROME	0.00369004	0.1476016
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00369004	0.1476016
SAGLIKER SYNDROME	0.00369004	0.1476016
CRISS-CROSS HEART	0.00369004	0.1476016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00369004	0.1476016
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.1476016
JOUBERT SYNDROME 35; JBTS35	0.00369004	0.1476016
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00369004	0.1476016
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00369004	0.1476016
7P22.1 MICRODUPLICATION SYNDROME	0.00369004	0.1476016
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.1476016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00369004	0.1476016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00369004	0.1476016
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00369004	0.1476016
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00369004	0.1476016
JABERI-ELAHI SYNDROME; JABELS	0.00369004	0.1476016
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00369004	0.1476016
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00369004	0.1476016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.1476016
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.1476016
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00369004	0.1476016
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.1476016
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00369004	0.1476016
XP22.13P22.2 DUPLICATION SYNDROME	0.00369004	0.1476016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00369004	0.1476016
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.1476016
KENNERKNECHT SYNDROME	0.00369004	0.1476016
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.1476016
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.1476016
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00369004	0.1476016
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00369004	0.1476016
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00369004	0.1476016
49,XYYYY SYNDROME	0.00353357	0.1413428
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00353357	0.1413428
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.00353357	0.1413428
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00353357	0.1413428
PRADER-WILLI-LIKE SYNDROME	0.00353357	0.1413428
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.1413428
SIALIDOSIS TYPE 1	0.00353357	0.1413428
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00353357	0.1413428
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00353357	0.1413428
CARPENTER-WAZIRI SYNDROME	0.00353357	0.1413428
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.1413428
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00353357	0.1413428
MUCOLIPIDOSIS TYPE III	0.00353357	0.1413428
RABSON-MENDENHALL SYNDROME	0.00353357	0.1413428
PITUITARY GIGANTISM	0.00353357	0.1413428
MUCOLIPIDOSIS TYPE IV	0.00353357	0.1413428
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00353357	0.1413428
ATHYREOSIS	0.00353357	0.1413428
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00353357	0.1413428
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00353357	0.1413428
GENITOPATELLAR SYNDROME	0.00353357	0.1413428
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00353357	0.1413428
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00353357	0.1413428
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00353357	0.1413428
NF1-MICRODELETION SYNDROME	0.00353357	0.1413428
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.1413428
2Q23.1 MICRODELETION SYNDROME	0.00353357	0.1413428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00353357	0.1413428
OGDEN SYNDROME	0.00353357	0.1413428
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.00353357	0.1413428
GENITOPATELLAR SYNDROME; GTPTS	0.00353357	0.1413428
SOTOS SYNDROME	0.00353357	0.1413428
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.1413428
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00353357	0.1413428
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00353357	0.1413428
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00353357	0.1413428
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00353357	0.1413428
FRONTOMETAPHYSEAL DYSPLASIA	0.00353357	0.1413428
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.1413428
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.00353357	0.1413428
COFFIN-LOWRY SYNDROME; CLS	0.00353357	0.1413428
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00353357	0.1413428
FABRY DISEASE	0.00353357	0.1413428
MENTAL RETARDATION, X-LINKED 103	0.00353357	0.1413428
ATKIN-FLAITZ SYNDROME	0.00353357	0.1413428
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00353357	0.1413428
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00353357	0.1413428
CLARK-BARAITSER SYNDROME	0.00353357	0.1413428
COFFIN-SIRIS SYNDROME 7; CSS7	0.00353357	0.1413428
MACS SYNDROME	0.00353357	0.1413428
LEUKOCYTE ADHESION DEFICIENCY	0.00353357	0.1413428
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00353357	0.1413428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00353357	0.1413428
COFFIN-SIRIS SYNDROME 5	0.00353357	0.1413428
DESANTO-SHINAWI SYNDROME	0.00353357	0.1413428
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00353357	0.1413428
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00353357	0.1413428
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00353357	0.1413428
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00353357	0.1413428
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.00353357	0.1413428
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00353357	0.1413428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.1413428
HELSMOORTEL-VAN DER AA SYNDROME	0.00353357	0.1413428
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00353357	0.1413428
SCHAAF-YANG SYNDROME; SHFYNG	0.00353357	0.1413428
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00353357	0.1413428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.00353357	0.1413428
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00353357	0.1413428
TRISOMY 17P	0.00353357	0.1413428
COFFIN-SIRIS SYNDROME 4; CSS4	0.00353357	0.1413428
COFFIN-SIRIS SYNDROME 3; CSS3	0.00353357	0.1413428
COFFIN-SIRIS SYNDROME 2; CSS2	0.00353357	0.1413428
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00353357	0.1413428
ATKIN-FLAITZ SYNDROME	0.00353357	0.1413428
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.00353357	0.1413428
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00353357	0.1413428
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.1413428
MUCOLIPIDOSIS III GAMMA	0.00353357	0.1413428
MUCOLIPIDOSIS III ALPHA/BETA	0.00353357	0.1413428
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00353357	0.1413428
FRANK-TER HAAR SYNDROME; FTHS	0.00353357	0.1413428
FRANK-TER HAAR SYNDROME	0.00353357	0.1413428
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00353357	0.1413428
CRANIODIAPHYSEAL DYSPLASIA	0.00353357	0.1413428
FOUNTAIN SYNDROME	0.00353357	0.1413428
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.1413428
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00353357	0.1413428
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00353357	0.1413428
FRYNS SYNDROME	0.00353357	0.1413428
GALACTOSIALIDOSIS	0.00353357	0.1413428
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.1413428
GM1 GANGLIOSIDOSIS	0.00353357	0.1413428
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.1413428
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.1413428
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.1413428
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.1413428
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.1413428
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.1413428
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.00353357	0.1413428
15Q OVERGROWTH SYNDROME	0.00353357	0.1413428
X-LINKED ACROGIGANTISM	0.00353357	0.1413428
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00353357	0.1413428
INFANTILE SYSTEMIC HYALINOSIS	0.00353357	0.1413428
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.1413428
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00353357	0.1413428
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00353357	0.1413428
268650 RUDIGER SYNDROME	0.00353357	0.1413428
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00353357	0.1413428
RIN2 SYNDROME	0.00353357	0.1413428
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00353357	0.1413428
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00353357	0.1413428
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00353357	0.1413428
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.1413428
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00353357	0.1413428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00353357	0.1413428
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00353357	0.1413428
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00342466	0.13698639999999998
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00342466	0.13698639999999998
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00342466	0.13698639999999998
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00342466	0.13698639999999998
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00342466	0.13698639999999998
IMMUNODEFICIENCY 49; IMD49	0.00342466	0.13698639999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.00342466	0.13698639999999998
THAKKER-DONNAI SYNDROME	0.00342466	0.13698639999999998
TRISOMY 8Q	0.00342466	0.13698639999999998
TRISOMY 18P	0.00342466	0.13698639999999998
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00342466	0.13698639999999998
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00342466	0.13698639999999998
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00342466	0.13698639999999998
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00342466	0.13698639999999998
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.13698639999999998
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00342466	0.13698639999999998
PENTASOMY X	0.00342466	0.13698639999999998
XIA-GIBBS SYNDROME	0.00342466	0.13698639999999998
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00342466	0.13698639999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00342466	0.13698639999999998
MENTAL RETARDATION, X-LINKED 90	0.00342466	0.13698639999999998
MENTAL RETARDATION, X-LINKED 21	0.00342466	0.13698639999999998
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00342466	0.13698639999999998
PSEUDOTRISOMY 13 SYNDROME	0.00342466	0.13698639999999998
260150 PALANT CLEFT PALATE SYNDROME	0.00342466	0.13698639999999998
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.13698639999999998
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00342466	0.13698639999999998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00342466	0.13698639999999998
EMANUEL SYNDROME	0.00342466	0.13698639999999998
YUNIS-VARON SYNDROME	0.00342466	0.13698639999999998
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00342466	0.13698639999999998
BOHRING-OPITZ SYNDROME	0.00342466	0.13698639999999998
PRADER-WILLI SYNDROME; PWS	0.00342466	0.13698639999999998
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00342466	0.13698639999999998
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00342466	0.13698639999999998
HYPERTELORISM, TEEBI TYPE; TBHS	0.00342466	0.13698639999999998
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00342466	0.13698639999999998
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00342466	0.13698639999999998
WIEACKER-WOLFF SYNDROME	0.00342466	0.13698639999999998
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00342466	0.13698639999999998
FRONTONASAL DYSPLASIA 2; FND2	0.00342466	0.13698639999999998
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00342466	0.13698639999999998
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00342466	0.13698639999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00342466	0.13698639999999998
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00342466	0.13698639999999998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00342466	0.13698639999999998
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00342466	0.13698639999999998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00342466	0.13698639999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00342466	0.13698639999999998
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00342466	0.13698639999999998
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00342466	0.13698639999999998
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00342466	0.13698639999999998
HUNTER-MACDONALD SYNDROME	0.00342466	0.13698639999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.00342466	0.13698639999999998
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00342466	0.13698639999999998
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00342466	0.13698639999999998
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00342466	0.13698639999999998
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00342466	0.13698639999999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00342466	0.13698639999999998
CZEIZEL-LOSONCI SYNDROME	0.00342466	0.13698639999999998
OTOONYCHOPERONEAL SYNDROME	0.00342466	0.13698639999999998
YUNIS-VARON SYNDROME	0.00342466	0.13698639999999998
MEND SYNDROME	0.00342466	0.13698639999999998
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.00342466	0.13698639999999998
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00342466	0.13698639999999998
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00342466	0.13698639999999998
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00342466	0.13698639999999998
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.00342466	0.13698639999999998
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00342466	0.13698639999999998
ISOTRETINOIN-LIKE SYNDROME	0.00342466	0.13698639999999998
GASTROCUTANEOUS SYNDROME	0.00342466	0.13698639999999998
FEMORAL-FACIAL SYNDROME	0.00342466	0.13698639999999998
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00342466	0.13698639999999998
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00342466	0.13698639999999998
5Q14.3 MICRODELETION SYNDROME	0.00342466	0.13698639999999998
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00342466	0.13698639999999998
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00342466	0.13698639999999998
CROSSED POLYSYNDACTYLY	0.00342466	0.13698639999999998
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00342466	0.13698639999999998
1P21.3 MICRODELETION SYNDROME	0.00342466	0.13698639999999998
LERI PLEONOSTEOSIS	0.00342466	0.13698639999999998
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0033349	0.133396
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0033349	0.133396
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0033349	0.133396
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.00170358	0.06814319999999999
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00170358	0.06814319999999999
RETT SYNDROME	0.00170358	0.06814319999999999
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00170358	0.06814319999999999
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00170358	0.06814319999999999
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00170358	0.06814319999999999
WILD TYPE ATTR AMYLOIDOSIS	0.00170358	0.06814319999999999
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.06814319999999999
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00170358	0.06814319999999999
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00170358	0.06814319999999999
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00170358	0.06814319999999999
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00170358	0.06814319999999999
WALDENSTRÖM MACROGLOBULINEMIA	0.00170358	0.06814319999999999
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.06814319999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00170358	0.06814319999999999
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00170358	0.06814319999999999
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.06814319999999999
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00170358	0.06814319999999999
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00170358	0.06814319999999999
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00170358	0.06814319999999999
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00170358	0.06814319999999999
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.06814319999999999
POLYMYOSITIS	0.00170358	0.06814319999999999
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00170358	0.06814319999999999
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.06814319999999999
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00170358	0.06814319999999999
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00170358	0.06814319999999999
AICARDI-GOUTIERES SYNDROME 7	0.00170358	0.06814319999999999
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00170358	0.06814319999999999
WOLMAN DISEASE	0.00170358	0.06814319999999999
MULIBREY NANISM	0.00170358	0.06814319999999999
ISOLATED COMPLEX I DEFICIENCY	0.00170358	0.06814319999999999
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00170358	0.06814319999999999
MAJEED SYNDROME	0.00170358	0.06814319999999999
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00170358	0.06814319999999999
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00170358	0.06814319999999999
PYCNODYSOSTOSIS	0.00170358	0.06814319999999999
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.06814319999999999
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00170358	0.06814319999999999
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.06814319999999999
INFANTILE REFSUM DISEASE	0.00170358	0.06814319999999999
FARBER DISEASE	0.00170358	0.06814319999999999
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.00170358	0.06814319999999999
GAUCHER DISEASE TYPE 2	0.00170358	0.06814319999999999
GAUCHER DISEASE TYPE 3	0.00170358	0.06814319999999999
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00170358	0.06814319999999999
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00170358	0.06814319999999999
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.06814319999999999
FISH-EYE DISEASE	0.00170358	0.06814319999999999
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00170358	0.06814319999999999
TAY-SACHS DISEASE	0.00170358	0.06814319999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00170358	0.06814319999999999
PROPIONIC ACIDEMIA	0.00170358	0.06814319999999999
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.06814319999999999
JUVENILE IDIOPATHIC ARTHRITIS	0.00170358	0.06814319999999999
MACROCEPHALY/AUTISM SYNDROME	0.00170358	0.06814319999999999
FETAL GAUCHER DISEASE	0.00170358	0.06814319999999999
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00170358	0.06814319999999999
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.00170358	0.06814319999999999
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00170358	0.06814319999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.06814319999999999
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.06814319999999999
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00170358	0.06814319999999999
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00170358	0.06814319999999999
PYRIDOXINE-DEPENDENT EPILEPSY	0.00170358	0.06814319999999999
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00170358	0.06814319999999999
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.06814319999999999
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00170358	0.06814319999999999
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00170358	0.06814319999999999
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.06814319999999999
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00170358	0.06814319999999999
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.06814319999999999
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00170358	0.06814319999999999
CRONKHITE-CANADA SYNDROME	0.00170358	0.06814319999999999
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00170358	0.06814319999999999
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00170358	0.06814319999999999
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.06814319999999999
HURLER-SCHEIE SYNDROME	0.00170358	0.06814319999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00170358	0.06814319999999999
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00170358	0.06814319999999999
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00170358	0.06814319999999999
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.06814319999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.00170358	0.06814319999999999
OPSISMODYSPLASIA	0.00170358	0.06814319999999999
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00170358	0.06814319999999999
PFAPA SYNDROME	0.00170358	0.06814319999999999
COMBINED SAPOSIN DEFICIENCY	0.00170358	0.06814319999999999
SANDHOFF DISEASE	0.00170358	0.06814319999999999
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00170358	0.06814319999999999
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00170358	0.06814319999999999
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00170358	0.06814319999999999
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00170358	0.06814319999999999
MIXED CONNECTIVE TISSUE DISEASE	0.00170358	0.06814319999999999
SHWACHMAN-DIAMOND SYNDROME	0.00170358	0.06814319999999999
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.06814319999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00170358	0.06814319999999999
KAGAMI-OGATA SYNDROME	0.00170358	0.06814319999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00170358	0.06814319999999999
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.00170358	0.06814319999999999
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.06814319999999999
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.06814319999999999
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00170358	0.06814319999999999
CLASSIC HODGKIN LYMPHOMA	0.00170358	0.06814319999999999
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.06814319999999999
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.06814319999999999
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00170358	0.06814319999999999
MASTOCYTOSIS	0.00170358	0.06814319999999999
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.06814319999999999
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00170358	0.06814319999999999
DENGUE FEVER	0.00170358	0.06814319999999999
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00170358	0.06814319999999999
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00170358	0.06814319999999999
BRONCHIAL NEUROENDOCRINE TUMOR	0.00170358	0.06814319999999999
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00170358	0.06814319999999999
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.06814319999999999
PLEURAL MESOTHELIOMA	0.00170358	0.06814319999999999
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00170358	0.06814319999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00170358	0.06814319999999999
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.06814319999999999
TANGIER DISEASE; TGD	0.00170358	0.06814319999999999
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.06814319999999999
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00170358	0.06814319999999999
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.06814319999999999
PROPIONIC ACIDEMIA	0.00170358	0.06814319999999999
MU-HEAVY CHAIN DISEASE	0.00170358	0.06814319999999999
MUCKLE-WELLS SYNDROME	0.00170358	0.06814319999999999
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00170358	0.06814319999999999
GAMMA-HEAVY CHAIN DISEASE	0.00170358	0.06814319999999999
CINCA SYNDROME	0.00170358	0.06814319999999999
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00170358	0.06814319999999999
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00170358	0.06814319999999999
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00170358	0.06814319999999999
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.06814319999999999
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00170358	0.06814319999999999
HB BART'S HYDROPS FETALIS	0.00170358	0.06814319999999999
HISTIOCYTOID CARDIOMYOPATHY	0.00170358	0.06814319999999999
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00170358	0.06814319999999999
AMISH LETHAL MICROCEPHALY	0.00170358	0.06814319999999999
TYPHOID	0.00170358	0.06814319999999999
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00170358	0.06814319999999999
CHÉDIAK-HIGASHI SYNDROME	0.00170358	0.06814319999999999
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.06814319999999999
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00170358	0.06814319999999999
COLD AGGLUTININ DISEASE	0.00170358	0.06814319999999999
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.06814319999999999
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00170358	0.06814319999999999
HODGKIN LYMPHOMA	0.00170358	0.06814319999999999
SCHNITZLER SYNDROME	0.00170358	0.06814319999999999
SEA-BLUE HISTIOCYTOSIS	0.00170358	0.06814319999999999
MAST CELL SARCOMA	0.00170358	0.06814319999999999
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.00170358	0.06814319999999999
FELTY SYNDROME	0.00170358	0.06814319999999999
GAUCHER DISEASE, TYPE IIIC	0.00170358	0.06814319999999999
OMENN SYNDROME	0.00170358	0.06814319999999999
GAUCHER DISEASE, TYPE II	0.00170358	0.06814319999999999
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00170358	0.06814319999999999
GAUCHER DISEASE, TYPE I	0.00170358	0.06814319999999999
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.00170358	0.06814319999999999
CUTANEOUS MASTOCYTOSIS	0.00170358	0.06814319999999999
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.06814319999999999
EISENMENGER SYNDROME	0.00170358	0.06814319999999999
GAPO SYNDROME; GAPOS	0.00170358	0.06814319999999999
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.06814319999999999
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00170358	0.06814319999999999
AMERICAN TRYPANOSOMIASIS	0.00170358	0.06814319999999999
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00170358	0.06814319999999999
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00170358	0.06814319999999999
RFT1-CDG	0.00170358	0.06814319999999999
PLAGUE	0.00170358	0.06814319999999999
ROIFMAN SYNDROME; RFMN	0.00170358	0.06814319999999999
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00170358	0.06814319999999999
ZIMMERMANN-LABAND SYNDROME	0.00170358	0.06814319999999999
COCKAYNE SYNDROME A; CSA	0.00170358	0.06814319999999999
PACHYONYCHIA CONGENITA	0.00170358	0.06814319999999999
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00170358	0.06814319999999999
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.06814319999999999
WHIPPLE DISEASE	0.00170358	0.06814319999999999
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.06814319999999999
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.06814319999999999
GLYCOGEN STORAGE DISEASE II	0.00170358	0.06814319999999999
LCAT DEFICIENCY	0.00170358	0.06814319999999999
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.06814319999999999
GLUTARIC ACIDEMIA I; GA1	0.00170358	0.06814319999999999
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00170358	0.06814319999999999
MYOTONIA PERMANENS	0.00163132	0.0652528
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.0652528
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.0652528
OROFACIODIGITAL SYNDROME VI	0.00163132	0.0652528
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.0652528
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.0652528
POTOCKI-SHAFFER SYNDROME	0.00163132	0.0652528
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.0652528
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00163132	0.0652528
ACROOTOOCULAR SYNDROME	0.00163132	0.0652528
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.0652528
48,XYYY SYNDROME	0.00163132	0.0652528
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.0652528
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00163132	0.0652528
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.0652528
DE BARSY SYNDROME	0.00163132	0.0652528
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.0652528
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.0652528
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.0652528
EPICANTHUS	0.00163132	0.0652528
JOUBERT SYNDROME 10	0.00163132	0.0652528
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00163132	0.0652528
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.0652528
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.0652528
ZUNICH NEUROECTODERMAL SYNDROME	0.00163132	0.0652528
BARATELA-SCOTT SYNDROME	0.00163132	0.0652528
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.0652528
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.0652528
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00163132	0.0652528
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00163132	0.0652528
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.0652528
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.0652528
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.0652528
JUBERG-MARSIDI SYNDROME	0.00163132	0.0652528
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.0652528
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00163132	0.0652528
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00163132	0.0652528
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00163132	0.0652528
ACRODYSOSTOSIS	0.00163132	0.0652528
MARTSOLF SYNDROME	0.00163132	0.0652528
EHLERS-DANLOS SYNDROME, TYPE VI	0.00163132	0.0652528
OHDO SYNDROME	0.00163132	0.0652528
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.0652528
MARDEN-WALKER SYNDROME	0.00163132	0.0652528
BRITTLE CORNEA SYNDROME	0.00163132	0.0652528
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00163132	0.0652528
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00163132	0.0652528
DISTAL TRISOMY 17Q	0.00163132	0.0652528
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.0652528
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00163132	0.0652528
DISTAL MONOSOMY 6P	0.00163132	0.0652528
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.0652528
9P13 MICRODELETION SYNDROME	0.00163132	0.0652528
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00163132	0.0652528
DESMOSTEROLOSIS	0.00163132	0.0652528
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.0652528
JACOBSEN SYNDROME	0.00163132	0.0652528
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.0652528
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.0652528
MOEBIUS SYNDROME; MBS	0.00163132	0.0652528
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.0652528
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00163132	0.0652528
ROTHMUND-THOMSON SYNDROME	0.00163132	0.0652528
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00163132	0.0652528
3P25.3 MICRODELETION SYNDROME	0.00163132	0.0652528
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.0652528
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.0652528
PTERYGIUM COLLI, ISOLATED	0.00163132	0.0652528
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.0652528
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00163132	0.0652528
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.0652528
PEHO SYNDROME; PEHO	0.00163132	0.0652528
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.0652528
ACROCALLOSAL SYNDROME; ACLS	0.00163132	0.0652528
XQ25 DUPLICATION SYNDROME	0.00163132	0.0652528
FETAL TRIMETHADIONE SYNDROME	0.00163132	0.0652528
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00163132	0.0652528
15Q11Q13 MICRODUPLICATION SYNDROME	0.00163132	0.0652528
MONOSOMY 22Q13.3	0.00163132	0.0652528
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.0652528
8Q12 MICRODUPLICATION SYNDROME	0.00163132	0.0652528
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00163132	0.0652528
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00163132	0.0652528
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00163132	0.0652528
BAKER-GORDON SYNDROME; BAGOS	0.00163132	0.0652528
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00163132	0.0652528
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00163132	0.0652528
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.0652528
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00163132	0.0652528
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00163132	0.0652528
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.0652528
MOEBIUS SYNDROME	0.00163132	0.0652528
FRAXE INTELLECTUAL DISABILITY	0.00163132	0.0652528
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00163132	0.0652528
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00163132	0.0652528
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00163132	0.0652528
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.0652528
1Q21.1 MICRODELETION SYNDROME	0.00163132	0.0652528
RING CHROMOSOME 14 SYNDROME	0.00163132	0.0652528
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00163132	0.0652528
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00163132	0.0652528
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00163132	0.0652528
LYMPHEDEMA, HEREDITARY, III	0.00163132	0.0652528
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00163132	0.0652528
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00163132	0.0652528
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.0652528
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.0652528
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00163132	0.0652528
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00163132	0.0652528
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00163132	0.0652528
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.0652528
PEHO-LIKE SYNDROME; PEHOL	0.00163132	0.0652528
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00163132	0.0652528
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00163132	0.0652528
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.0652528
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.0652528
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.0652528
XQ25 MICRODUPLICATION SYNDROME	0.00163132	0.0652528
BRADDOCK SYNDROME	0.00163132	0.0652528
TRISOMY XQ28	0.00163132	0.0652528
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00163132	0.0652528
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.0652528
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.0652528
TOLUENE EMBRYOPATHY	0.00163132	0.0652528
PHENOBARBITAL EMBRYOPATHY	0.00163132	0.0652528
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.0652528
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.0652528
RENAL AGENESIS, BILATERAL	0.00163132	0.0652528
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.0652528
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.0652528
FETAL VALPROATE SYNDROME	0.00163132	0.0652528
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00163132	0.0652528
CUTIS LAXA	0.00163132	0.0652528
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.0652528
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.0652528
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.0652528
17Q21.31 MICRODUPLICATION SYNDROME	0.00163132	0.0652528
MOWAT-WILSON SYNDROME	0.00163132	0.0652528
CAREY-FINEMAN-ZITER SYNDROME	0.00163132	0.0652528
HALL-RIGGS SYNDROME	0.00163132	0.0652528
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.0652528
RING CHROMOSOME 6 SYNDROME	0.00163132	0.0652528
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00163132	0.0652528
RING CHROMOSOME 8 SYNDROME	0.00163132	0.0652528
GMS SYNDROME	0.00163132	0.0652528
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.0652528
KNOBLOCH SYNDROME	0.00163132	0.0652528
MONOSOMY 18P	0.00163132	0.0652528
3Q13 MICRODELETION SYNDROME	0.00163132	0.0652528
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00163132	0.0652528
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00163132	0.0652528
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00163132	0.0652528
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00163132	0.0652528
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.0652528
CHROMOSOME 18Q DELETION SYNDROME	0.00163132	0.0652528
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00163132	0.0652528
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00163132	0.0652528
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00163132	0.0652528
CEREBROOCULONASAL SYNDROME	0.00163132	0.0652528
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00163132	0.0652528
PHELAN-MCDERMID SYNDROME	0.00163132	0.0652528
STICKLER SYNDROME	0.00163132	0.0652528
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00163132	0.0652528
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.0652528
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00163132	0.0652528
JOUBERT SYNDROME 3; JBTS3	0.00163132	0.0652528
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.0652528
NOONAN SYNDROME 3; NS3	0.00163132	0.0652528
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00163132	0.0652528
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00163132	0.0652528
6P22 MICRODELETION SYNDROME	0.00163132	0.0652528
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00163132	0.0652528
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00163132	0.0652528
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.0652528
PHAVER SYNDROME	0.00163132	0.0652528
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.0652528
SCARF SYNDROME	0.00163132	0.0652528
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.0652528
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00163132	0.0652528
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.0652528
PENOSCROTAL TRANSPOSITION	0.00163132	0.0652528
PEHO SYNDROME	0.00163132	0.0652528
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.0652528
WRINKLY SKIN SYNDROME	0.00163132	0.0652528
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00163132	0.0652528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00163132	0.0652528
POTOCKI-SHAFFER SYNDROME	0.00163132	0.0652528
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00163132	0.0652528
NOONAN SYNDROME 4; NS4	0.00163132	0.0652528
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00163132	0.0652528
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.0652528
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00163132	0.0652528
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00163132	0.0652528
MONOSOMY 9Q22.3	0.00163132	0.0652528
NOONAN SYNDROME 8; NS8	0.00163132	0.0652528
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.0652528
HARTSFIELD SYNDROME; HRTFDS	0.00163132	0.0652528
14Q12 MICRODELETION SYNDROME	0.00163132	0.0652528
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00163132	0.0652528
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00163132	0.0652528
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.0652528
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00163132	0.0652528
MOMO SYNDROME	0.00163132	0.0652528
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.0652528
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00163132	0.0652528
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.0652528
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.0652528
20P12.3 MICRODELETION SYNDROME	0.00163132	0.0652528
2P15P16.1 MICRODELETION SYNDROME	0.00163132	0.0652528
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.0652528
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00163132	0.0652528
HADZISELIMOVIC SYNDROME	0.00163132	0.0652528
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00163132	0.0652528
OPITZ G/BBB SYNDROME	0.00163132	0.0652528
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.0652528
NOONAN SYNDROME 6; NS6	0.00163132	0.0652528
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00163132	0.0652528
JOUBERT SYNDROME 14	0.00163132	0.0652528
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00163132	0.0652528
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.0652528
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.0652528
KEIPERT SYNDROME	0.00163132	0.0652528
14Q22Q23 MICRODELETION SYNDROME	0.00163132	0.0652528
MECKEL SYNDROME, TYPE 10; MKS10	0.00163132	0.0652528
FRONTORHINY	0.00163132	0.0652528
